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Abstract 
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Major Department: Health Education & Promotion 
Background – The field of immunizations has grown in recent years with the 
introduction of new vaccines for adolescents and adults.  Despite these advances, 
adolescents and adults are often under-immunized and may be susceptible to the effects 
of harmful diseases.  A need exists to expand venues in which adolescents and adults can 
receive vaccines, and to educate health care providers about the existence and importance 
of administering immunizations to these age groups.  In particular, obstetrician-
gynecologists (OB/GYNs) are in a unique position to make a significant impact on 
immunization education and vaccination rates for women of all ages.  Yet, researchers 
know little about their vaccination practices and opinions about immunizations.   
Objective – The purpose of this phenomenological study was to explore how 
obstetrician-gynecologists perceived and defined their role in immunization and vaccine 
administration, including providing patient education about immunizations.  In addition, 
the researcher was interested in identifying the meaning that study participants’ derived 
from the practice of immunizing and the influences that have impacted their adolescent 
and adult immunization practices.   
Methods – To achieve this purpose, the researcher conducted in-depth, open-
ended interviews with 13 OB/GYNs in North Carolina.  A qualitative methodology using 
a phenomenological approach enabled the researcher to better understand participants’ 
immunization-related beliefs, perspectives, and behaviors related to their role in 
providing patient education and administering vaccines.  Analysis of verbatim 
transcriptions of the interviews involved immersion, coding, categorizing, and identifying 
themes that emerged from the data. 
Results – While the participants in this study were willing to educate their patients 
about vaccines, their view of their role in terms of vaccination and primary care varied by 
provider.  Four themes emerged from the data in this study that related to the participants’ 
experiences with immunizations: the vaccination experience, role inconsistency, multiple 
barriers to providing immunizations, and the decision to immunize.  The data also 
provided a rich description of the meanings that study participants derived from the 
practice of immunizing and the influences that impacted their immunization decisions.   
Conclusions – Health educators and other public health professionals can use the 
data collected during the course of this study to determine possible strategies for 
adopting, expanding and improving adolescent and adult immunization services among 
OB/GYNs.  Insights gleaned from study findings may, in time, lead to the immunization 
of greater proportions of female adolescents and adults and reduced morbidity and 
mortality associated with vaccine-preventable diseases within these populations. 
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CHAPTER 1:  INTRODUCTION 
The Centers for Disease Control & Prevention (CDC) have recognized vaccines 
as one of the top ten greatest achievements of public health in the 20th century (CDC, 
1999).  Vaccines are responsible for the complete eradication of smallpox, and the near 
elimination of polio, rubella, and diphtheria diseases in the United States.  In addition, 
vaccines have greatly reduced the incidence of other diseases such as measles, mumps 
and Haemophilus influenzae type b (Hib).         
The success of childhood vaccines has led to recent exponential growth in the 
field of immunizations due to the development of vaccines for diseases that commonly 
affect adolescent and adult populations.  The rapid growth in the number of new vaccines 
for adolescents and adults has strained the public health infrastructure both in terms of its 
ability to finance the cost of the vaccines and to effectively reach and administer vaccines 
to these new populations.  A need exists to expand venues in which adolescents and 
adults can receive vaccines, and to educate health care providers about the existence and 
importance of administering immunizations to these age groups.  However, researchers 
know little about the vaccination practices and opinions of non-traditional vaccine 
providers. One health care provider group in particular has the potential to make a 
significant impact on immunization education and vaccination rates for women of all 
ages.  This group is obstetrician-gynecologists (OB/GYNs) in private practice.   
Between 2005 and 2008, the Centers for Disease Control & Prevention’s 
Advisory Committee on Immunization Practices (ACIP) made a record number of new 
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vaccination recommendations for adolescents and adults (CDC, 2007a).  Four new 
vaccines recommended during this three-year period include:    
• MCV4 - protects against meningococcal disease: recommended in 2005 for 
adolescents 11-18 years of age (CDC, 2005b); 
• Tdap - protects against tetanus, diphtheria and pertussis: recommended in 2006 
for adolescents 11-18 years of age and for all adults 19-64 years of age (CDC, 
2006a; CDC, 2006b); 
• HPV - protects against human papillomavirus: recommend in 2007 for females 
between 9 and 26 years of age (CDC, 2007d); and  
• Herpes Zoster - protects against shingles: recommended in 2008 for adults over 
60 years of age (CDC, 2008b).   
The ACIP has recommended routine vaccination in adolescent populations with 
three principal vaccines: meningococcal conjugate vaccine (MCV4); the combination 
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine; and 
human papillomavirus (HPV) vaccine (for girls only).  Each of these vaccine 
recommendations reinforce the importance of routine vaccination during a 
comprehensive health care visit suggested for all 11 to 12 year olds (CDC, 2007a).  
According to the CDC,  
The introduction of these new vaccines offers an opportunity to reduce morbidity 
and mortality among adolescents, enhance their uptake of other preventive 
services, and heighten awareness of the importance of disease prevention through 
lifelong use of recommended vaccines and other services. (CDC, 2007a, p.1)    
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The need for increased education and vaccination efforts among adults is also 
critical.  “Adults, not children, are now at greater risk of death due to vaccine-preventable 
diseases” (Gall, 2003, p. 37).  In recent years, the ACIP has recommended several new 
vaccines for adults such as HPV, Tdap and Herpes Zoster (shingles).  In addition, the 
ACIP has recommended older vaccines such as influenza, pneumococcal, and hepatitis B 
for adults for many years.  These new and existing vaccines can positively impact the 
health of adults through the enhancement of their administration (CDC, 2007b).   
However, despite ACIP recommendations and high levels of immunization 
coverage among children, most adolescents and adults are not up-to-date with the 
recommended vaccinations (National Foundation for Infectious Diseases [NFID], 2008a; 
NFID, 2008b).   According to the results from the 2007 National Immunization Survey – 
Teen, about one-third (32.4%) of adolescents between 13 and 17 years of age in the 
United States reported receiving the meningococcal vaccine.  For Tdap, 30.4% of 
adolescents between 13 and 17 years of age reported receiving one dose and 72.3% 
reported receiving a dose of either Td or Tdap (CDC, 2008d).  One quarter (25.1%) of all 
adolescent females reported receiving at least one of the three recommended doses of 
HPV vaccine (CDC, 2008d).  Data specific to North Carolina’s adolescent immunization 
rates for these vaccines were not available at the time of this study.   
For adults, the highest immunization coverage rates are for vaccines that have 
been available for the longest period of time.  Nationally, during the 2006-07 influenza 
season, 37.3% of all adults 18-49 years of age, 42.2% of all adults 50-64 years of age, 
and 68.8% of all adults over 65 years of age were vaccinated against influenza (National 
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Immunization Survey [NIS], 2007).  For pneumococcal, 65.6% of adults over 65 years of 
age reported ever receiving this vaccine (NIS, 2007).   
In North Carolina, the rates for influenza vaccination are slightly higher than 
national rates.  During the 2006-07 influenza season, 46.6% of all North Carolina adults 
aged 50-64 years of age and 72.6% of all adults over 65 years of age received the 
influenza vaccine (CDC, 2008c).  For pneumococcal, the rates were similar to the 
national average, with 62.6% of adults between 65 and 74 and 77.5% of adults 75 years 
of age and older reporting having ever received this vaccine (North Carolina State Center 
for Health Statistics, 2007).   
For the newer adult vaccines, immunization rates are much lower nationally (NIS, 
2007).  Only 2.1% of adults in the United States reported receiving a dose of Tdap in the 
past two years; 1.9% of adults 60 and older reported ever receiving a dose of 
zoster/shingles vaccine; and 9.9% of females 18-26 years of age reported ever receiving 
one or more doses of HPV vaccine (NIS, 2007).  North Carolina data regarding the 
coverage rates of adults with these vaccines were not available at the time of this study.   
Increasing vaccination coverage rates among adolescents and adults has remained 
a challenge for several reasons.  For adolescents, few immunization initiatives exist that 
attempt to improve adolescent vaccination coverage rates and services.  Limited funding 
for an immunization infrastructure and issues related to adolescents’ access to health care 
effect outreach to this population (CDC, 2007a).  As the CDC observes,  
Adolescents generally seek recommended preventive health services less 
frequently than children in other age groups and often don’t have an identified 
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medical home, which can make it difficult for health care providers to promote 
vaccines among this age group. (CDC, 2007a, p.2)   
For adults, the main barrier to improving vaccination rates is similar to that of 
adolescents:  a lack of awareness about the need for immunizations during adulthood and 
the lack of an immunization infrastructure.  In addition, resources to finance vaccines for 
adults who are uninsured or underinsured are nonexistent (CDC, 2007b).  A final barrier 
that affects both adolescents and adult vaccination rates are concerns about vaccine safety 
and side effects.  Concerns that the vaccines may actually cause the disease; that the 
vaccination may cause harm; that the immunization will be painful, or a fear of needles 
are all contributors to low immunization rates among adolescents and adults (Logan, 
2008).   
In order to reach adolescents and adults, the CDC suggests that state 
immunization programs expand awareness of vaccinations among health care providers 
and increase outreach to individuals through health care settings that do not traditionally 
offer immunization services (i.e., colleges, STD clinics, emergency departments, family 
planning clinics, OB/GYN offices, and pharmacies) (CDC, 2007b).  “High overall 
immunization coverage rates can potentially be achieved by complimenting efforts of 
primary care physicians with efforts to deliver vaccines in other health care settings that 
adolescents and adults tend to frequent” (Schaffer et al., 2008, p. S36).     
One health care setting that is positioned to positively impact adolescent and adult 
immunization rates is obstetrician-gynecologists’ medical practices.  Obstetrician-
gynecologists have the ability and opportunity to educate and administer vaccines to 
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women of all ages because the majority of these physicians serve both adolescent and 
adult populations (Gonik, Jones, Conteras, Fasano, & Roberts, 2000).  These physicians 
not only provide pregnancy-related health care, but also treat non-pregnant women, many 
of whom may not have another health provider for primary health care (Gall, 2003; 
Schrag et al., 2003).  While few adolescents under the age of 15 see OB/GYNs, a study 
by Schaffer et al. (2008) found that, for women between 17 and 21 years of age, one-third 
of all medical visits were to OB/GYNs. Women over the age of 18 visited OB/GYNs 
more than any other type of physician (Rand et al., 2007).     
Research Questions 
While OB/GYNs have the opportunity and ability to educate and vaccinate the 
women that they serve, their willingness to do so remains unclear.  Even though evidence 
suggests that most OB/GYNs believe that the provision of vaccines should be within their 
scope of work, they may still feel hesitant to participate in immunization programs 
(Gonik et al., 2000).  A need exists to investigate the perceptions of OB/GYNs regarding 
the meanings they assign to and the role and responsibility they associate with 
immunizations.  More specifically, the researcher seeks to investigate several 
immunization-related questions from the perspective of OB/GYNs:  What do they 
perceive their responsibility to be with patient education about immunizations and 
vaccine administration?  How do they define their role in immunizing?  What does it 
mean to the OB/GYN to serve as a vaccinator?  What benefits and barriers do they 
encounter or expect to encounter when offering vaccines? Where do immunizations fit 
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within the realm of routine obstetrician-gynecologist care?  What experiences have 
influenced their immunization practices?   
Data on obstetrician-gynecologists’ attitudes and practices related to vaccine-
preventable disease is critical in determining the success of the adoption, expansion, and 
improvement of adolescent and adult immunization services within this setting.  In this 
study, the researcher sought to understand the perceptions of obstetrician-gynecologists 
regarding immunizations by exploring their experiences with and perceptions about 
vaccines, vaccine-related patient education, and the “contexts or situations that have 
influenced or affected their experience” (Creswell, 2007, p. 61) with immunizing.   
Significance of Study 
Understanding how OB/GYNs’ perceive and define their role in immunizations 
and the influences that have impacted their immunization practices is important for a 
number of reasons.  First, understanding OB/GYNs’ perspectives about educating their 
patients about and administering specific vaccines will provide insight into the 
development and implementation of successful educational outreach programs that will 
encourage the expansion of vaccine services to patients served by this physician group.  
Enhanced vaccination services will enable obstetrician-gynecologists to reduce the 
burden of vaccine-preventable diseases among the patients they serve.  Adolescents and 
adults who are unimmunized are vulnerable to the effects of a variety of diseases, many 
of which can have negative health outcomes for the individual or the fetus.   
Secondly, awareness of the reasoning underlying OB/GYNs’ perceived 
responsibility and role in immunizations has implications for the services or vaccines 
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offered by physicians in this specialty. Gaining insight into OB/GYNs’ vaccine-related 
perceptions can lead to the development of strategies that can change practice patterns.  
Such strategies, in turn, may lead to more physicians in the specialty initiating vaccine-
related patient education efforts and administering vaccines to their patients, thereby 
protecting the women they serve against a wider variety of vaccine-preventable diseases.  
Because obstetrician-gynecologists treat a wide age range of women who might not see 
another physician, these specialists represent an optimal opportunity to educate and 
vaccinate the adolescent and adult women who use their services.  
Third, understanding the situations that have shaped OB/GYNs’ practice patterns 
regarding immunization has implications for the development of successful outreach 
programs to expand the state’s immunization program.  At the time of this study, the 
vaccination program in the State of North Carolina provided vaccines for children under 
the age of 18 years to providers at no charge.  Since the majority of OB/GYNs offer 
services to adolescent-aged individuals, they have the opportunity to offer free vaccine to 
the patients they serve if they join the state’s immunization program  Access to free 
vaccines for adolescents has the potential to reduce physicians’ out-of-pocket costs 
associated with providing immunizations for their patients under 18 years of age. 
A fourth reason why this research is important is that, at the time of this study, 
few qualitative studies have sought to understand the immunization-related practices and 
beliefs of OB/GYNs.  Several quantitative studies have assessed OB/GYNs’ opinions and 
practice patterns about various aspects of their medical practice, including 
immunizations, but few have attempted to understand the reasoning behind their 
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immunization-related beliefs and actions.  Gaining insight into these physicians’ 
perceptions and experiences regarding vaccinations will add depth to the existing 
literature about this issue.  This research will provide a rich description of the OB/GYNs’ 
experience with adolescent and adult immunizations.  Lastly, a qualitative approach may 
lead to the development or identification of additional research needed in this area.   
Statement of Purpose 
The purpose of this study was to explore how obstetrician-gynecologists 
perceived and defined their role in providing patient education about immunizations and 
administering vaccines.  In addition, the researcher sought to identify the meaning 
OB/GYNs assigned to the practice of immunizing and the influences that impacted their 
immunization practices for adolescents and adults. 
Definition of Terms 
Adolescent – Any individual between 10 and 19 years of age (World Health 
Organization, 2009). 
Advisory Committee on Immunization Practices (ACIP) – A group of experts in 
immunizations that are appointed by the Secretary of the Department of Health and 
Human Services to provide advice and guidance to the CDC and DHHS on the control of 
vaccine-preventable diseases (CDC, 2008a).   
Diphtheria – An infectious disease caused by bacteria that live in the mouth, throat and 
nose of an infected person. It can lead to breathing problems, paralysis, and heart failure. 
Diphtheria is fatal for 10% of those affected (CDC, 2007c).   
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Gardasil –The brand name of the Human Papillomavirus (HPV) vaccine, it protects 
against 4 types of HPV virus, two of which cause 70% of cervical cancer and two that 
cause 90% of genital warts. 
Haemophilus influenzae type B (Hib) - An infectious organism that can cause meningitis 
(an infection of the covering of the brain and spinal cord), pneumonia (lung infection), 
epiglottitis (a severe throat infection), and other serious infections.  Hib disease spreads 
through the air by coughing, sneezing, and breathing (CDC, 2007c).    
Health Care Provider or Provider – Any medical professional (doctor, nurse, medical 
assistant, etc.) who provides health care services to the public.   
Hepatitis A - A virus that causes serious liver disease, Hep A is found in the stool of 
infected persons.  The disease spreads by close personal contact or by eating something 
that contains the virus.  It can cause a mild flu-like illness, jaundice, severe stomach pains 
and diarrhea (CDC, 2008e).   
Hepatitis B – A virus that is most common cause of liver cancer in the world.  The virus 
attacks the liver and can cause lifelong infection, scarring of the liver, liver cancer, liver 
failure, and death.  The disease spreads through contact with the blood or other body 
fluids of an infected person (CDC, 2008e).   
Herpes Zoster (shingles) - Caused by the varicella zoster virus (VZV), the same virus that 
causes chickenpox, this disease causes a painful, blistering rash. Anyone who has had 
chickenpox can develop shingles. Shingles most commonly occurs in people 50 years old 
or older (CDC, 2008e).   
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Human Papillomavirus (HPV) – Spread through sexual contact, HPV is a virus most 
commonly seen in those in their late teens and early 20s. It is the major cause of cervical 
cancer in women and can also cause genital warts (CDC, 2008e).   
Influenza – Commonly called “the flu,” this is a contagious respiratory illness caused by 
influenza viruses. It can cause mild to severe illness, and can lead to death (CDC, 2007c).    
Measles – An infectious viral disease that begins with a fever that lasts for a couple of 
days, measles infection follows with a cough, runny nose, conjunctivitis, and rash.  It is 
the most deadly of all childhood illnesses associated with a rash and fever (CDC, 2008e).   
Meningococcal disease - A serious, highly contagious illness caused by bacteria that 
causes a potentially fatal infection of the lining around the brain and spinal cord.  It can 
also infect the bloodstream, which can result in the loss of an arm or leg (North Carolina 
Immunization Branch, 2008a).    
MCV4 - The meningococcal vaccine (MCV4) offers protection against four of the five 
most common types of meningococcal infection.  This vaccine is normally given in one 
dose during the routine preadolescent immunization visit (at 11-12 years), although all 
children and adolescents 11 through 18 years of age are recommended to receive the 
vaccine (North Carolina Immunization Branch, 2008a).    
Mumps – Best known for the swelling around the jaw that develops with this disease, 
mumps virus causes fever, headache, and swollen glands.  It can lead to deafness, 
meningitis (infection of the brain and spinal cord covering), painful swelling of the 
testicles or ovaries, and, death (CDC, 2007c).     
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Pertussis – Also called whooping cough, it is a highly contagious bacterial infection that 
causes severe spasms of coughing that can last for several weeks or months. Pertussis 
usually spreads from person-to-person through close contact when a person coughs or 
sneezes (CDC, 2007c).   
Polio – A virus that lives in the throat and intestinal tract causes polio. It has caused 
paralysis in millions of children worldwide over the years and spreads mainly through 
contact with the feces of an infected person (CDC, 2007c).     
Pneumococcal – Pneumococcal disease is an infection caused by a type of bacteria.  
Depending on where these bacteria invade the body, they can cause pneumonia (if enters 
the lungs); bacteremia (if enters the bloodstream); or meningitis (if enters the tissues and 
fluids surrounding the brain and spinal cord) (North Carolina Immunization Branch, 
2008b).    
Pneumovax – The brand name of the pneumococcal vaccine, it helps protect against 
multiple types of pneumococcal disease.  The ACIP recommends this vaccine for all 
adults over the age of 65.   
Rubella – Typically a mild disease caused by a virus, rubella causes a slight fever, a rash 
on the face and neck, and swollen glands in the back of the neck and arthritis-like 
symptoms in the joints. It spreads from person to person through the air, by coughing, 
sneezing or breathing. It is particularly harmful to unborn babies (CDC, 2007c).   
Tdap (Tetanus, Diphtheria, Pertussis) – A vaccine that can protect adolescents and adults 
against three serious diseases: tetanus, diphtheria, and pertussis. The ACIP recommends 
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Tdap for all adolescents beginning at 11 or 12 years of age and for all adults between 18 
and 64 years of age (CDC, 2007c).     
Tetanus – Also called lockjaw, tetanus is a serious disease caused by bacteria that can 
cause a painful tightening of the muscles all over the body. The term lockjaw describes 
the effects of this disease, in that a victim’s mouth can be come locked so that they are 
unable to open their mouth or swallow.  Tetanus is fatal in 10% of cases (CDC, 2008e).   
Td vaccine –A vaccine that offers protection from tetanus and diphtheria, the Td vaccine 
can be given to children seven years of age and older and for adults.  It is for routine 10-
year boosters (CDC, 2007c).      
Thesis Overview 
In the chapters that follow, the researcher will examine the existing research 
literature on the topic of vaccines and vaccination, discuss phenomenology as the study 
approach and study methods associated with the approach, present study findings, discuss 
the findings using a theoretical framework, and explore implications for further study and 
health education.  Chapter 2 will present findings from the research literature as it relates 
to the vaccination practices and opinions of OB/GYNs, the opinions of OB/GYNs on 
their role as primary care providers and vaccinators, and the recommendations from the 
American College of Obstetricians and Gynecologists (ACOG) about vaccinations.   
Chapter 3 will describe specifics of the proposed study, including: the rationale for using 
a qualitative, phenomenological approach; strategies to establish credibility; 
qualifications of the researcher; methods to ensure participants’ rights are protected;  
procedures for selecting participants; plans to manage the collection of data; and 
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processes for data analysis.  Charter 4 will present the results from the study, including 
the vaccination experience in the OB/GYNs’ practice; the OB/GYNs’ defined role with 
immunizations and primary care; the identified barriers to immunizing; and the 
components of the OB/GYNs’ decision to immunize.  Chapter 5 will offer a discussion of 
the key findings that incorporates the research literature and theoretical framework of the 
study.  In addition the researcher will explore implications for the field of health 
education and promotion and for future research.   
 
CHAPTER 2:  REVIEW OF THE LITERATURE 
Because of their “unique access to women at all stages of life – who often consult 
no other physician – Ob/Gyns are well positioned to proclaim and bestow the benefits of 
vaccination” (Gall, 2003). Although no qualitative studies have explored vaccination-
related meaning, perceptions, or experiences of OB/GYNs, a number of quantitative 
studies have evaluated the vaccination practices and opinions of OB/GYNs.  Some of 
these studies focused on their practices and opinions regarding a specific vaccine, while 
others focused on their practice and perceptions in vaccinating a specific population.  
Additional research has focused on the OB/GYNs’ role as vaccinator or primary care 
provider or the impact of the American College of Obstetricians and Gynecologists’ 
(ACOG) recommendations on vaccination practices.  A review of these findings from the 
research literature follows.   
Vaccination Practices of Obstetrician-Gynecologists 
The vaccination practices of OB/GYNs vary according to number of vaccines 
available they offer, the levels of immunization knowledge of the OB/GYNs, and the 
patient populations they serve.  A quantitative study that surveyed approximately 600 
members of the American College of Obstetricians and Gynecologists (ACOG) by 
Schrag et al. (2003) found that the majority (64%) of OB/GYNs across the country 
affiliated with medical practices that offered at least one vaccine to their patients.  The 
most common vaccines they offered were rubella and influenza vaccines, followed by 
hepatitis B vaccine and tetanus toxoid-diphtheria vaccine (Td) (Schrag et al., 2003).   A 
small proportion (10%) of these medical practices offered their patients every available 
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vaccine recommended for pregnant or postpartum women (Schrag et al., 2003).   In 
addition, the study found that less than 60% of OB/GYNs regularly inquired about the 
patients’ immunization or disease history (Schrag et al., 2003).   
Other studies have examined the immunization knowledge of OB/GYNs.  For 
example, a study by Gonik et al. (2000) assessed the immunization knowledge of 313 
ACOG members in Michigan using survey questionnaires.  The researchers found a 
significant variation in physicians’ awareness and understanding of vaccine 
recommendations, vaccine safety, and vaccine administration.  
Due to the morbidity and mortality associated with influenza in pregnant women 
and their infants, health care professionals consider influenza vaccination an important 
component of prenatal care.  It has also been one of the most common vaccines offered 
by OB/GYNs (ACOG, 2004).  A CDC report in 2005, however, indicated that many 
OB/GYNs were not following the updated ACIP recommendations regarding influenza 
vaccination because they were not vaccinating pregnant women during the first trimester 
of pregnancy.  As a result of these findings, the CDC recommended improving public 
health efforts to educate OB/GYNs about current recommendations on the use of 
influenza vaccine during pregnancy (CDC, 2005a).  In addition, the report identified the 
need for more research on effective strategies to increase the availability and 
administration of influenza vaccine in the OB/GYN setting (CDC, 2005a).  By following 
these recommendations from the CDC, OB/GYNs could potentially, “play a pivotal role 
in helping to protect women and newborns from this vaccine-preventable disease” (CDC, 
2005a, p. 1052).   
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Additional research studies examined OB/GYNs’ opinions and practice patterns 
relating to the Tdap and HPV vaccines.  The ACIP recommends Tdap vaccination for all 
adults between 19 and 64 years of age.  The vaccine is particularly important for anyone 
who has or might have contact with an infant less than one year of age (CDC, 2006b).  
By surveying a national random sample of 212 obstetricians, Clark, Adolphe, Davis, 
Cowan and Kretsinger (2006) examined obstetricians’ perceptions about providing Tdap 
vaccine to postpartum mothers, pregnant women, and adults expected to come in close 
contact with infants.  Study findings revealed that the majority of obstetricians 
acknowledged their role in promoting or providing education about the Tdap vaccine to 
individuals coming in close contact with infants (in addition to the mother) (Clark et al., 
2006). The obstetricians perceived a shared responsibility to promote Tdap vaccine with 
other health care providers, such as adult primary care providers, pediatricians, and 
public health providers (Clark et al., 2006). Study participants believed that adult primary 
care providers had a larger role in administering the Tdap vaccine than did obstetricians, 
pediatricians and public health providers (Clark et al., 2006).     
The ACIP recommends all females between 11 and 12 years of age receive the 
three-dose series of the human papillomavirus (HPV) vaccine.  Females between the ages 
of 13 and 26 years should also receive the HPV vaccine, if they did not receive it at 11 or 
12 years of age.  Girls as young as nine years of age can also receive this vaccine (CDC, 
2007d).  The American College of Obstetricians and Gynecologists (ACOG) indicated 
that, although OB/GYNs may not treat or serve many females between 11 to 12 years of 
age for whom the vaccine is recommended, they will likely provide care for older 
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females between the ages of 13 and 26 years and can be instrumental in the adoption and 
use of this vaccine among this older population (ACOG, 2006a).  In addition, ACOG’s 
Committee on Obstetric Practice believed that health care visits by females between 16 
and 26 years of age for any service, such as primary care, contraceptive, or pregnancy-
related services presented “a strategic time to discuss HPV and the potential benefit of 
HPV vaccine and to offer vaccination to those who have not already received it” (ACOG, 
2006a, p. 701).   
To date, researchers know little about the HPV vaccination practices of 
OB/GYNs.  By 2008, health professionals largely assumed that many OB/GYNs had the 
HPV vaccine available in their offices and were administering it (Gall, 2008).  However, 
few studies have investigated the proportion of OB/GYNs who provide the vaccine.  One 
small, unpublished study found that 64% of the obstetrics-gynecology practices in a four-
county area in North Carolina offered the HPV vaccine (Gottlieb, Brewer, Smith, Keating 
& Markowitz, 2008). 
OB/GYNs have the training and knowledge to treat pregnant women for a variety 
of health concerns, including the effects of vaccine-preventable diseases on the pregnant 
woman and her fetus.  In addition, these health care providers commonly screen their 
pregnant patients for potential health risks to the developing fetus, such as hepatitis B or 
rubella.  If screening revealed a need for preventative treatment, OB/GYNs tend to 
provide the necessary immunization, either immediately or post-partum (Gonik et al., 
2000).  For OB/GYNs who did not provide vaccines to their patients, barriers identified 
by Schrag et al. (2003) included vaccination-associated costs, beliefs that other primary 
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care providers should provide vaccinations, and lack of adequate vaccine storage and 
handling facilities.  
While the vaccination practices and opinions of OB/GYNs vary by vaccine type 
and population group, studies that have assessed these issues have been primarily 
quantitative in design.  Findings from these studies have offered important data, but lack 
the rich, thick description that enhances insight and understanding of these issues.  A 
need exists for a deeper understanding of the “why” underlying the vaccination-related 
patient education and practice patterns of OB/GYNs.  A qualitative research approach 
can optimally obtain such an understanding.  
Obstetrician-Gynecologists’ Opinion of Role as  
Primary Care Providers & Vaccinators 
Women of childbearing age have often visited their OB/GYN for annual 
preventive care and may have considered their OB/GYN to be their primary care provider 
(Stovall, Loveless, Walden, Karjane, & Cohen, 2007).  OB/GYNs themselves, however, 
do not necessarily share patients’ views of their position as primary care providers.   
Stovall et al. (2007) surveyed over 130 OB/GYNs in the Mid-Atlantic region and found 
that this provider group primarily viewed themselves as specialists who also provided 
primary care for women.  They also found that the majority of physicians disagreed when 
asked if they wanted to include primary care in their practice (Stovall et al., 2007).  
Despite a self-perception as specialist rather than primary care provider, Gonik et al. 
(2000) found that OB/GYNs were familiar with some aspects of primary care and had 
provided the following primary care services for some time: screening for cancers 
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(breast, skin, cervical); screening and treatment of sexually-transmitted diseases, and  
contraceptive management.   
The role of OB/GYNs as primary care providers does not extend to women of all 
ages.  Elderly women, for example, are less likely to receive such care from their 
OB/GYNs.  Medicare claims data from Washington residents revealed that elderly 
patients over age 65 years received a limited amount of non-gynecologic care from 
OB/GYNs (Fink et al., 2001).  Thus, while Gonik et al. (2000) observed that OB/GYNs 
served as primary care providers for women of reproductive age (i.e., from adolescence 
to menopause), Fink et al. (2001) established that older age women were less likely to 
receive such care from their OB/GYNs. 
An OB/GYN’s decision to provide vaccines has been associated with two 
variables: working in a multispecialty practice and self-identification as a primary care 
provider (Schrag et al., 2003).  When asked their opinion about vaccinations, most 
OB/GYNs believed that the provision of vaccines should be within the scope of their 
responsibilities (Gonik et al., 2000).  However, this belief is often not put into practice, as 
the Gonik et al. study (2000) also revealed a discrepancy that existed “between perceived 
responsibility and actual practice patterns of obstetrician-gynecologists regarding 
vaccine-preventable diseases and the immunization of women” (Gonik et al., 2000, p. 
81).   
Research studies that have been conducted to date have only identified this 
discrepancy and reported about OB/GYNs’ perceptions as they relate to their role in 
immunization.  Data that is rich and thick in description that specifically address the 
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reasons behind this disconnect between perceived responsibility and actual practice 
patterns is needed to fully understand OB/GYNs’ attitudes and behaviors related to 
immunization practices.  Without understanding vaccination practices, the expansion of 
vaccination services into this setting will be limited.    
In fact, there have been few studies that have used a qualitative approach to 
examine OB/GYNs’ perspectives and opinions about health care-related issues. One 
qualitative study examined OB/GYNs’ and other health providers’ perceptions about 
their role in addressing health-related issues outside of routine obstetric and gynecologic 
services (Herzig et al., 2006).  The researchers examined OB/GYNs’, nurse practitioners’ 
and certified nurse midwives’ practices regarding four behavior risks in their pregnant 
patients: alcohol use, smoking, drug use, and domestic violence.  The study participants 
“saw behavioral risk prevention as a challenging but important part of their role as 
prenatal providers” (Herzig et al., 2006, p. 96).  The researcher was able to identify other 
studies that assessed the OB/GYNs’ perspectives and opinions about their role with other 
components of health care, such as depression screening services or educating their 
pregnant patients about the infant hepatitis B vaccination; however, these studies were all 
quantitative in design (Zola, Smith, Goldman, & Woodruff, 1997; LaRocco-Cockburn, 
Melville, Bell & Katon, 2003).    
American College of Obstetricians and Gynecologists’ (ACOG)  
Vaccine Recommendations 
According to OB/GYNs, recommendations from the American College of 
Obstetricians and Gynecologists (ACOG) are highly influential in their decision to 
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incorporate newly licensed vaccines into their medical practice (Schrag et al., 2003).  The 
American College of Obstetricians and Gynecologists (ACOG) is a nonprofit 
organization of board-certified OB/GYNs.  It is the leading group of physicians in the 
United States providing health care for women (ACOG, 2009).   
In addition, more than 90% of OB/GYNs surveyed “felt ACOG should make the 
development of educational tools related to vaccination of obstetrician-gynecologists’ 
patients a moderate or high priority” (Schrag et al., 2003, p. 708).  These findings imply 
that OB/GYNs may be willing to consider or more fully implement immunization 
services within their medical practices (Schrag et al., 2003).  Therefore, ACOG’s support 
on this issue is a critical determinant of the expansion of immunization services into this 
setting.     
Fortunately, ACOG has long supported recommendations by the Advisory 
Committee on Immunization Practices (ACIP) on HPV vaccination, influenza 
vaccination, meningococcal vaccination, rubella vaccination, and the vaccination of 
pregnant women and has published Committee Opinions encouraging OB/GYNs to 
follow these guidelines (ACOG, 2002; ACOG, 2003; ACOG, 2004; ACOG, 2005b; 
ACOG, 2006a).  While ACOG has not published specific Committee Opinions for the 
Tdap, hepatitis B, hepatitis A, pneumococcal, or shingles vaccines, immunizations are a 
component of their recommendations for routine assessments for all age groups.  In 2006, 
ACOG published a list of all of the screenings, health topics, and laboratory tests that 
should be included in a periodic assessment with individuals in each of four age groups 
beginning at age 13 years. The assessment list for every age group included numerous 
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vaccines.  For example, in the Periodic Assessment for 13-18 year olds, ACOG included 
the Tdap, Hep B, HPV and meningococcal vaccines on its list of recommendations for 
this age group (ACOG, 2006b).  In addition, ACOG has issued a Committee Opinion that 
identifies assessing a patient’s immunization history as an important component of 
preconception care (ACOG, 2005a).   
OB/GYNs are at the forefront of the immunization issue, largely due to the 
addition of new vaccine initiatives.  These new vaccine initiatives include those focused 
on early newborn infectious disease such as influenza and pertussis; sexually transmitted 
diseases such as hepatitis B and HPV; and cancer prevention such as hepatitis B and HPV 
(Gonik, Fasano & Foster, 2002).  The advent of the human papillomavirus (HPV) 
vaccine, in particular, has renewed interest among OB/GYNs to expand their vaccination 
offerings because of the direct impact this vaccine can have on cervical cancer rates.   
ACOG recently published an editorial in their clinical review publication that 
calls for OB/GYNs to expand their immunization services beyond the HPV vaccine to 
include other important vaccines for adolescents and adults (Gall, 2008).  The vaccines 
that ACOG recommends that OB/GYNs offer include influenza, hepatitis B, Tdap, 
pneumococcal, herpes zoster, and meningococcal (Gall, 2008).  The ACOG editorial 
argues that if the office’s workflow is already “set up to administer the HPV vaccine, 
providing additional vaccines would be an extra benefit to the patients and practice” 
(Gall, 2008, p. 16). Due to OB/GYNs’ increasing levels of experience with the 
administration, storage, handling, and billing associated with vaccines, the author of this 
editorial believed that OB/GYNs should be ready and able to offer a complete 
24  
 
immunization package of services, including patient education, for all of the vaccines 
recommended for adolescents and adults (Gall, 2008).   
ACOG’s favorable stance on an issue is a prerequisite to the adoption of the 
behavior by OB/GYNs (Schaffer et al., 2008).  While researchers have studied OB/GYNs 
to determine the impact such recommendations have on immunization practices, 
information is lacking about how ACOG’s support of OB/GYNs as complete vaccine 
providers will affect physicians’ behaviors.  Information is also lacking about how 
ACOG’s influence will impact physicians’ perceptions about the benefits of and barriers 
to expanding immunization services.   
Summary 
Some quantitative studies have assessed the practice patterns and opinions of 
OB/GYNs regarding vaccinations.  Research has examined these physicians’ behavior 
and opinions about specific vaccines, their vaccination of specific populations, and the 
impact of recommendations from their national organization on their decisions to 
immunize.  Gaps exist in the research related to OB/GYNs’ perceptions of immunizations 
and vaccination practices that a qualitative research approach can help to fill.  
Understanding OB/GYNs’ perceptions about offering vaccine-related patient education, 
administering specific vaccines, immunization-related responsibilities and practices, and 
benefits and barriers to offering enhanced immunization services will be instrumental in 
the successful adoption of expanded vaccine services among this physician group.   
The researcher sought to address this research need by means of a qualitative 
approach.  She strove to achieve an in-depth understanding of how OB/GYNs’ perceived 
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and defined their roles in providing immunization-related patient education and 
administering vaccines.  The purpose of this study was also to identify the meaning 
OB/GYNs ascribed to vaccines and the practice of vaccination and analyzed the 
situations that influenced their immunization practices.  
This study held implications for the field of health education and promotion, as its 
findings offered potential insights into how health educators could best develop effective 
outreach programs that encouraged the expansion of vaccination services among 
OB/GYNs.  Insights gleaned from study findings may, in time, lead to the immunization 
of greater proportions of female adolescents and adults and the reduced morbidity and 
mortality associated with vaccine-preventable diseases among these populations.  In 
addition, findings from this study may point to the need for additional research in this 
area.   
 
CHAPTER 3:  METHODOLOGY 
The researcher designed this study to explore how OB/GYNs perceived, defined 
and derived meaning from their role in immunizations.  In addition, the researcher was 
interested in understanding the influences that impacted their immunization practices.  To 
achieve these purposes, the researcher used a qualitative methodology with a 
phenomenological approach to explore the meaning immunizations held for OB/GYNs.   
Rationale for Selecting Qualitative Methods 
The researcher selected a qualitative methodology for several reasons.  
Researchers commonly use qualitative research when a problem or issue needs further 
exploration.  The research studies that have examined the perceptions and vaccination 
practices of OB/GYNs have been primarily quantitative in design.  While these studies 
provide important data, a gap exists in understanding that a qualitative research design 
can optimally fill.  A qualitative approach can provide an in-depth understanding of this 
issue and add to the body of research knowledge.  The use of a qualitative research 
design to study this topic will produce a rich, deep description (Ploeg, 1999) of 
OB/GYNs experiences and perceptions about immunization. 
A second reason for the selection of a qualitative design for this study is because 
the researcher sought to understand participants’ feelings, beliefs, attitudes, and opinions 
with respect to immunizations.  As Creswell suggests, qualitative research can provide,  
a complex, detailed understanding of the issue.  This detail can only be 
established by talking directly with people, going to their homes or places of 
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work, and allowing them to tell the stories unencumbered by what we expect to 
find or what we have read in the literature. (Creswell, 2007, p. 40)   
Through the use of in-depth, open-ended interviews, the researcher hoped to develop a 
thorough understanding of the perceptions and influences that have impacted OB/GYNs’ 
immunization practices.  Understanding their beliefs, attitudes, and perceptions about 
vaccinations may help state immunization programs develop initiatives tailored for this 
provider group.  In addition, this information may lead to an expansion of immunization 
services within this physician population that will reach vulnerable adolescent and adult 
populations.   
The final reason the researcher selected a qualitative design for this study is that 
the researcher wanted to better understand the influences that have impacted the 
participants’ immunization practices.  According to Ploeg, “The purpose of qualitative 
research is to describe, explore, and explain phenomena being studied” (1999, p. 36).  
Understanding the context behind the immunization beliefs and practices of OB/GYNs 
may help immunization professionals who are interested in changing the vaccination 
education and practice patterns of these health care providers.    
Phenomenological Approach 
For this study, the researcher selected a phenomenological approach to qualitative 
research.  Phenomenology refers to a qualitative approach that seeks to understand and 
describe the meaning that a particular phenomenon (in this case, immunizations) has to a 
specific group of people.  The purpose of phenomenology is to condense the individual 
experiences with the phenomenon to a summation of the overall essence of experience 
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(Creswell, 2007). This researcher selected this approach for three main reasons.  First, 
she was interested in describing the meaning that OB/GYNs’ derived from their lived 
experiences with immunizations.  Because the researcher sought to describe the 
“essence” of immunizations as understood from a range of physicians’ perceptions and 
experiences with immunizations, she selected the phenomenological approach for its 
emphasis on the experiences of multiple people.  “The aim of a phenomenological 
approach to qualitative research is to describe accurately the lived experiences of people, 
and not to generate theories or models of the phenomenon being studied” (Ploeg, 1999, p. 
36).  Through the utilization of this approach, the researcher was able to describe the 
“essence” of OB/GYNs’ experiences with immunizations and to develop a deeper 
understanding about this topic.   
A second reason that the researcher selected a phenomenological approach for 
this study was the nature of the research question of interest.  The researcher was 
interested in learning about the perceptions of OB/GYNs regarding the meanings they 
assign to and the roles and responsibilities they associated with immunizations.  The 
researcher was also interested in investigating several other immunization-related 
questions from the perspective of OB/GYNs.  In-depth interviews provided the means for 
best answering these open-ended research questions.  In phenomenological studies, in-
depth interviews with multiple participants are commonly used.   
Because the primary source of data is the life world of the individual being 
studied, in-depth interviews are the most common means of data collection.  
Furthermore, emerging themes are frequently validated with participants because 
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their meanings of that lived experience are central in phenomenological study. 
(Ploeg, 1999, p. 36) 
    The third reason for the selection of the phenomenological approach was that the 
researcher wanted to inquire about the participants’ experiences with immunizations and 
the context or influences that have impacted their experiences with immunizations.  This 
type of questioning has been commonly associated with phenomenological studies and 
would generate data that was descriptive of the individual and shared experiences of the 
participants.   
Theoretical Framework 
The theoretical framework of Health Belief Model (HBM) informed the design of 
this research study.  The model suggests that a person’s perceptions influence the 
likelihood that they engage in the recommended health action.  By changing their 
perceptions, the likelihood increases that they will act on the health behavior 
recommendation (Hodges & Videto, 2005). 
The HBM consists of four main components: perceived severity, perceived 
susceptibility, perceived benefits, and perceived barriers.  Individuals determine a 
perceived threat based on their assessment of the perceived susceptibility and severity of 
the situation.  “Perceived benefits and perceived barriers to engaging in the recommended 
action are weighed, along with perceived level of threat and self-efficacy related to the 
specific behavior, to produce the likelihood of action” (Hodges & Videto, 2005, p. 104).  
Cues to action are another aspect of this model in that they help start the desired 
behavior.   
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According to the HBM, improving the individual’s knowledge about the health 
problem in terms of its true susceptibility, severity, benefits, and barriers can have lasting 
effects on the individual’s health behavior.  In keeping with this model, the researcher 
strove to understand the perceived benefits and barriers that the OB/GYNs associated 
with the practice of immunizing.  In addition, the researcher sought to explore the 
perceived threat that vaccine-preventable diseases represented for their patients and the 
meaning that providers assigned to the practice of immunizing.      
Measures to Address Credibility 
In qualitative studies, a credible or valid study is one in which the findings 
accurately represent the experiences, opinions and perspectives of the participants. To 
establish credibility with the research design, the researcher utilized several strategies.  
These strategies included reflexivity, bracketing, member checks, finding confirming and 
disconfirming evidence, maintaining an audit trail, using thick description, and peer 
review.   
Reflexivity 
The way in which the researcher understood and analyzed the data collected in 
this study involved interpretation.  The researcher engaged in reflexivity in order to study 
the findings of the research completely.  Reflexivity refers to the process by which the 
researcher examines her own interpretations and assumptions about the findings and how 
they potentially could affect the study.  By engaging in reflexivity, the researcher was 
able to identify her own biases and take the necessary precautions to make sure they were 
not present in the final research paper.  Once the researcher knew her biases, she was able 
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to make an interpretation of what she had learned from the participants in a way shaped 
in full awareness of the researcher’s own experiences and background.   
Bracketing 
Prior to conducting the interviews and throughout the interview process, the 
researcher bracketed her biases, preconceptions, and beliefs about the research topic.  
Bracketing refers to a process by which the researcher writes about personal theories, 
previous awareness, and lived experiences with the phenomenon so that she or he is able 
to look at the issue without preconceptions (Richards & Morse, 2007).   The purpose of 
bracketing was to enable the researcher to “set aside… [her] experiences, as much as 
possible, to take a fresh perspective toward the phenomenon under examination” 
(Creswell, 2007, p. 59-60).  By identifying her biases through the bracketing process 
before and during the interviewing process, the researcher was able to ensure that her 
experiences were not influencing how she understood the experiences of the participants 
in the study.   
It is particularly important for researchers to acknowledge and describe their 
entering beliefs and biases early in the research process to allow readers to 
understand their positions, and then to bracket or suspend those research biases as 
the study proceeds. (Creswell & Miller, 2000, p. 127)   
Member Checks 
The researcher strove to ensure that her findings accurately reflected the 
participants’ experiences and perspectives.  To do so, she offered all the interview 
participants a copy of the report for member checking, and asked them if she accurately 
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represented their beliefs, experiences, and perceptions.  The researcher incorporated their 
feedback into the final version of the report. This process of member checking added 
credibility to the study because it ensured that the findings were a true representation of 
the participants’ perspectives.   
Confirming and Disconfirming Evidence 
Another way in which the researcher attempted to establish credibility with this 
research was by understanding findings in the context of the existing research literature.  
In addition to literature that supported the findings of this research, the researcher tried to 
find disconfirming or negative evidence in the study data.  By searching for 
disconfirming, as well as confirming evidence within the data provided by participants, 
the researcher was able to provide additional support for the study’s findings (Creswell & 
Miller, 2000).  However, the researcher did not find any disconfirming evidence among 
the participants.   
Audit Trail 
A fifth way in which the researcher attempted to establish credibility with the 
research was by maintaining an audit trail that consisted of a four components:  a 
personal journal, a research log, the researcher’s analytic memos, and field notes.  The 
personal journal involved the researcher engaging in both reflection about the study’s 
progress and bracketing and reflexivity about the researcher’s perceptions.  In addition, 
the researcher maintained a research log containing a chronology of all events and 
contacts associated with the study as well as all decision points and action steps taken.  
The audit trail also included the researcher’s memos regarding ongoing insights and 
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reflections about data analysis and interpretation of data and the field notes, which 
consisted of handwritten notes taken during and immediately after the interviews.   These 
audit trail components enabled external researchers to examine the research data to 
confirm that findings were grounded in the data; to assess if the inferences were logical; 
to ascertain how or if the researcher’s bias influenced the report; and to evaluate if the 
strategies used to increase the credibility of the report were successful (Creswell & 
Miller, 2000).   
Thick Description 
A sixth way the researcher added credibility to the study was through the use of 
thick, rich description.  “The purpose of thick description is that it creates verisimilitude, 
[which are] statements that produce for the readers the feeling that they have experienced, 
or could experience, the events being described in the study” (Creswell & Miller, 2000, p. 
128-129).  These enhanced details allow readers to have a better sense of the issue under 
investigation, and contributes to the credibility of findings.  
Peer Review 
Lastly, the researcher incorporated peer review while drafting the final report to 
add credibility to the study.  Peer review refers to the “review of the data and research 
process by someone who is familiar with the research or the phenomenon being 
explored” (Creswell & Miller, 2000, p. 129).  Tesha Lucas, a graduate student at East 
Carolina University who is also conducting a phenomenological study for her thesis 
project, served as the peer reviewer for this study.  Her role in this position was to offer 
suggestions and support to the researcher; to ask questions about the methodology and 
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interpretations of the findings; and to challenge the assumptions that the researcher made 
about the data.  Tesha had multiple opportunities to review the data and findings over the 
course of the study, and her feedback and suggestions added credibility to the study. 
Qualitative researchers need to demonstrate that their study is credible.  This 
researcher incorporated a variety of methods in her research design to ensure that the 
findings from her study were credible and representative of the opinions, perspectives, 
and experiences of the participants.  These methods help readers and fellow researchers 
understand that the findings are reliable.   
Researcher Qualifications & Biases 
Amanda Dayton was the principal investigator for this study.  She was 
responsible for all activities associated with this project including: recruiting and 
enrolling participants for the study; obtaining informed consent from participants; 
conducting and transcribing the interviews; analyzing the results and reporting the 
findings.  Amanda Dayton is a graduate student currently enrolled in the Department of 
Health Education & Promotion program at East Carolina University.  She has 
successfully completed a graduate-level qualitative research course (HLTH 6700) and has 
experience interviewing individuals and groups.   
Prior to beginning the study, the researcher engaged in reflexivity and bracketing 
to understand her preconceptions, biases, and assumptions about the study’s topic.  This 
was also an on-going process throughout the course of the study.  At the beginning of the 
study, the researcher was aware of several personal preconceptions, assumptions and 
biases.  First, the researcher acknowledged an assumption that vaccinations were 
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important in maintaining the health of all people.  She believed that, in most cases, 
vaccines had more positive than negative effects on individuals who received them.  
While the researcher recognized that not all people shared this belief or experience, she 
assumed that all health care providers, regardless of their specialty, supported the 
administration of vaccines.   
A second assumption the researcher held related to her current professional role as 
the Adolescent Immunization Coordinator for the Immunization Branch of the State of 
North Carolina.  As part of her employment, she was responsible for recruiting and 
enrolling new vaccine providers who served adolescent populations, including those who 
were non-traditional providers.  She assumed that she would be able to use the 
information collected as a consequence of the study to develop outreach initiatives or 
projects to enroll OB/GYNs into the state’s vaccine program.   
Throughout the research process, the researcher recorded her biases, opinions, and 
perceptions about this study in her research journal.  She attempted to identify the areas 
she might take for granted in undertaking the research, potential areas for conflict, and 
any non-neutral feelings she had relating to the issues she studied in general and 
participants’ perspectives in particular.  For example, during the course of the interviews, 
the researcher had to make sure not to convey her opinions and biases about what 
vaccines she thought the OB/GYNs should offer to the participants.  The researcher 
recognized her bias about what she thought OB/GYNs should be providing.  In order to 
prevent communication of her bias to study participants, she refrained from making 
comments or communicating through body language her approval or disapproval about 
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their vaccination practices or beliefs.  If the participants asked how their practice 
compared to others or “what they could be doing better,” the researcher waited until after 
the conclusion of the interview to educate study participants about vaccine 
recommendations.   
Occasionally, during the course of the interview, the OB/GYN would make a 
statement about vaccines that was inaccurate.  During those times, the researcher tried to 
make sure her body language and her comments did not convey her true feelings about 
the remark nor did the researcher correct the participant.  She tried to maintain a neutral 
presence, and simply listen to what the OB/GYN had to say about vaccines.  
   The process of continuing engagement in reflexivity and bracketing enabled the 
researcher to become aware of her biases and assumptions.  Therefore, their influence on 
the data collection and analysis process diminished (Ahern, 1999).   By using these tools, 
the researcher maintained neutrality throughout the study and maintained a focus on the 
participants’ meaning, rather than her own (Creswell, 2007).   
Protection of Study Participants 
Prior to beginning data collection, the researcher described the purpose, risks, and 
benefits associated with the study to the participants.  She also explained how she would 
maintain participants’ confidentiality and both her role and the participant’s role in the 
study.  This enabled each participant to make an informed decision about study 
participation.   
  The researcher obtained a signed informed consent document (Appendix E) prior 
to the facilitation of the interview, in accordance with the requirements of the University 
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Medical Center and Institutional Review Board of East Carolina University who 
approved the study (Appendix F).  Prior to beginning the interview, the researcher 
requested that the participants read and sign the informed consent document.  She then 
addressed any questions that arose about the study or the informed consent document.  
The informed consent document explained that participation was voluntary.  If the 
participant declined to continue with the study, the participant was able to leave the 
interview without penalty.  The researcher ensured that the informed consent document 
was easy for the participants to understand.  Since the study focused on college-educated, 
practicing OB/GYNs, there were no need to obtain informed consent from participants 
with limited or low literacy.   
Participants who volunteered to be a part of this study met the researcher at an 
agreed-upon, private, and mutually convenient location that was determined by the 
researcher and participant.  If an in-person interview was not possible, the interview took 
place over the telephone.  Only one of the thirteen interviews occurred over the 
telephone.      
Participants in the study remained anonymous.  The researcher altered any 
personally identifying data linked with the participant and assigned pseudonyms to 
participants during data collection and analysis and in written findings.  Only the 
researcher had access to data associated with the study.  In keeping with university 
guidelines, the researcher will store audio-recordings, verbatim transcripts, and all other 
data associated with the study in a locked container in the researcher’s home for a period 
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of three years.  After three years, the researcher will shred the written data and destroy 
the audio-recordings.    
Study participation involved participants’ willing and voluntary engagement in 
one in-depth, open-ended interview.  During data collection, transcription, and analysis, 
the researcher used pseudonyms in place of participants’ names.  The researcher was the 
only person who collected and transcribed data.  She and her research committee 
members had access to the pseudonym-protected transcribed data during the data analysis 
phase of the study.  The researcher removed all identifiers that could directly link the 
participants to their comments from the transcripts and the study report.  These actions 
ensured the protection of the participants’ privacy if future researchers used data from 
this study. 
Procedures for Identifying and Selecting Informants 
The researcher used a purposive sample of OB/GYNs for participation in this 
study.  “Qualitative research is generally based on non-probability and purposive 
sampling rather than probability or random approaches.  Sampling decisions are made for 
the explicit purpose of obtaining the richest possible source of information to answer the 
research questions” (Ploeg, 1999, p. 36).   
Identifying Participants 
The researcher conducted in-depth, open-ended, audio-recorded interviews with 
13 practicing OB/GYNs who resided and practiced medicine in North Carolina at the 
time of the study.  Twelve of the interviews occurred in-person, and one occurred over 
the telephone.  In order to sample OB/GYNs with a range of perceptions and experiences 
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related to practice-based immunization administration, the researcher tried to recruit 
OB/GYNs with a variety of vaccination offerings.  The final sample consisted of one 
OB/GYN specialist who, as a consultant, did not offer vaccines of any kind to his 
patients; seven OB/GYNs who provided between one and three vaccines; and five 
OB/GYNs who provided four or more vaccines.   
Because of the interpretive nature and design of the study, the researcher sought a 
small number of participants.  Phenomenological research reports and studies suggest that 
between five and 25 individuals be interviewed (Creswell, 2007).  A small number of 
non-randomly sampled individuals were ideal for this qualitative study because the 
researcher was interested in obtaining an in-depth understanding of the issue.  The 
researcher expected the data collection process for this study to take a long time and 
require careful attention to detail.  Therefore, the sample size in this study was smaller, 
which has the potential to affect the breadth of findings.  However, the depth of the 
findings in this qualitative research was more detailed and complete than previously 
found in quantitative research to date.  
The researcher employed several different strategies for recruiting participants for 
this research project.  She created an advertising flyer that described the research and 
provided contact information that could be distributed (Appendix A).  To maintain 
confidentiality, the flyer asked potential participants to initiate contact with the researcher 
by telephone.  In addition to personal and professional contacts, the researcher distributed 
the flyer as described below.    
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The researcher identified potential study participants by means of network 
sampling.  She initiated contact with employees within the State Division of Public 
Health and informed staff within the Immunization Branch and other sections within 
Public Health about her study.  She notified those who had the potential to help her 
identify OB/GYNs about her study, distributed the advertising flyer to them, and 
requested that they contact any OB/GYNs on her behalf using the flyer or provide contact 
information for potential participants.  Upon receipt of contact information, the 
researcher then contacted the physicians directly.  Utilizing these methods, the researcher 
was able to identify four of the study participants.   
The most effective strategy that the researcher used to identify study participants 
was personal contacts.  Three of the researcher’s friends were able to recommend 
OB/GYNs as potential study participants and disseminated the research flyer on the 
researcher’s behalf.  These friends were able to find four OB/GYNs for the researcher, all 
of whom agreed to participate in the study.  The researcher’s family was also helpful in 
finding OB/GYNs for the study.  Two family members were able to recommend a total of 
three OB/GYNs for study participation and disseminated the research flyer on the 
researcher’s behalf.  All three of those OB/GYNs also agreed to participate.  One member 
of the researcher’s thesis advisory committee recommended and referred a participant for 
the study, and the final OB/GYN found to participate in the study was the researcher’s 
personal OB/GYN.   
The researcher utilized other methods of recruiting OB/GYNs without success.  
The Executive Director for the Wake County Medical Society mailed a letter to all of the 
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OB/GYNs residing in Wake County (approximately 50 OB/GYNs).  The letter included a 
personal introduction from the executive director and abbreviated information from the 
researcher’s advertising flyer (Appendix B).  None of the OB/GYNs contacted in this 
manner contacted the researcher for an interview.   
The researcher also attempted to work with the sales force manager of a local 
pharmaceutical company.  This sales force calls almost exclusively on OB/GYNs across 
the state, and had indicated a willingness to allow her staff to distribute flyers about the 
study to those practices.  However, the researcher never implemented this method of 
recruitment because of concerns raised by the pharmaceutical company’s legal 
department.  Another ineffective way in which the researcher tried to recruit OB/GYNs 
was by enlisting the aid of the North Carolina OB/GYN Society.  The researcher 
successfully contacted the head of the North Carolina OB/GYN Society, and this person 
agreed to help disseminate the advertising flyer about the study.  However, subsequent 
attempts to contact this person were unanswered, and the researcher is unclear if this 
organization disseminated any information about her study.  The researcher also 
attempted to reach potential participants by cold-calling practices.  This method was not 
effective, as none of the potential participants contacted in this manner agreed to an 
interview.   
The researcher faced difficulty in finding OB/GYN practices that did not offer 
vaccines.  Through the use of cold-calling and recommendations from some of the 
participants and Division of Public Health Staff, the researcher was able to identify four 
OB/GYN offices that did not offer any vaccines to their patients.  Three of these practices 
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declined interviews and the fourth never returned any of the phone messages left by the 
researcher.   
In summary, the most effective means of recruiting participants for this study was 
through the use of network sampling.  The researcher was able to identify potential 
participants based on recommendations from friends, family, and professional colleagues.  
She then followed-up with these contacts to determine the physician’s willingness to 
participate.  Having a recommendation of someone who might be willing to participate, 
or having a third-party who knew a physician personally contact them on the researcher’s 
behalf about the study proved to be the most effective way to recruit the participants.  
Using methods such as cold-calling practices or working with professional associations 
was not effective recruiting method for this study.   
Selecting Participants 
The researcher selected participants based on their willingness to participate and 
the number of vaccines provided in their office.  Participants included those with limited 
experience with vaccines, as the researcher was interested in interviewing OB/GYNs with 
a wide variety of background and experience with immunizations.  They did not have to 
currently administer vaccines or be a part of the Immunization Branch’s vaccine 
distribution program to participate.  The only requirement to participate was holding 
current licensure to practice as an OB/GYN in the state of North Carolina.  Participation 
in this research was voluntary.  The researcher offered no incentives to participants for 
participation in the research study.   
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Data Collection Methods 
The researcher conducted one audio-recorded, in-depth interview with each 
participant during which the interviewer used an interview guide (Appendix C).  Topics 
covered during each interview included participants’ overall impressions and concerns 
about immunizations, how they viewed their professional responsibility related to 
vaccinations, how they defined their role in immunization, their perceptions of the 
benefits and barriers to offering vaccines, where immunizations fit within the realm of 
routine obstetric-gynecologic care, and the experiences that had influenced their 
immunization practices.  The interviews lasted between 30 minutes and one hour.  
Data Management Plan 
The researcher employed a data management plan to organize and manage the 
data collection process and data itself.  She also maintained an audit trail that enabled 
other researchers to understand the events and choices that influenced the interpretations 
and conclusions of the research process.  The audit trail and data management plan 
helped to establish credibility for this research by providing details about the data 
collection and analysis process (Wolf, 2003).  To document the research process, the 
researcher’s audit trail consisted of the components outlined below.  
Research Log  
The researcher maintained a dated research log that detailed all of the activity and 
decision points that occurred during the course of the research study.  This log included 
events, activities and decision points related to the study.  It also contained notes about 
the rationale for any decisions or changes in the research.  
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Field Notes  
The researcher kept copies of all handwritten notes taken during and immediately 
after the interviews.  The field notes taken during the interview included short, jotted 
comments about what the participants said and what the researcher observed while they 
were talking.  Immediately after the interview session, the researcher developed an 
expanded version of the notes to fully describe what happened during the interview 
session.   
Research Journal  
The researcher maintained a research journal during the course of the study to 
write about her personal reactions to the research activities, and examine her 
preconceptions, assumptions, and biases.  This dated journal included the researcher’s 
personal opinions about how the study is progressing and the challenges and frustrations 
experienced by the researcher during the study.  This component was important so that 
the researcher was aware of any biases or assumptions that may have the potential to 
impact the validity and credibility of the research findings.   
Analytic Memos 
A fourth part of the audit trail was the analytic memos.  These memos consisted 
of the researcher’s insights, and preliminary analysis of the collected data.  These dated 
memos attempted to explain how the researcher was making sense of the data collected.  
The researcher reviewed these memos throughout the course of the study to clarify 
information and identify potential research themes.   
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In addition to the four components described above, the researcher supplemented 
the audit trail with raw data (such as the transcribed interviews and audio-recordings of 
the interview session), UMCRIB approval and closure documents, research literature and 
articles related to the study, a researcher-developed codebook, and copies of all of the 
rough drafts of the final report, as well as the reviewers’ feedback.   The researcher 
backed up all the audit trail data frequently and will keep it in a locked container for a 
minimum of three years.  The researcher maintained the individual privacy of each 
participant throughout the study, in all components of the audit trail.  While the 
researcher collected demographic data for the participants, she reported it only in 
aggregate.  No unique identifiers linked data to the participants’ responses.  All data were 
documented anonymously using pseudonyms.   
Data Analysis 
The data analysis process began during the interview sessions.  During this time, 
the researcher took careful notes pertaining to the participant’s responses, as well as their 
tone and body language when answering the questions.  This information enhanced the 
understanding of the interview context to bring depth to the quality of data.    
 Immediately upon completion of the interview, the researcher transcribed the 
sessions verbatim. The interview transcripts were prepared using the audio-recorded data 
and field notes taken during the session.  The researcher double-checked each transcript 
against the recording to ensure accuracy. 
  From this point, the data analysis process followed four main steps: immersion; 
coding of data; creation of categories; and identification of themes.  Once the 
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transcriptions were complete, the researcher read and re-read them multiple times, which 
contributed to her immersion in the data.  “Data immersion brings about clarity of the 
part played by both the interviewer and the research participant, and lays the foundation 
for connecting disjointed elements into a clearer picture of the issue being investigated”  
(Green et al., 2007, p. 547).  The researcher made every attempt to immerse herself in the 
data early and often, in order to make the data analysis process more manageable and 
effective.    
  The second step the researcher took to analyze the data generated from the 
interviews was to code the information.  The coding process involved examining and 
organizing the data from each interview into meaningful segments with descriptive labels 
(Creswell, 2007).  To code, the researcher examined a block (or line) of text and asked 
‘What is this participant saying?’  The researcher then labeled the transcribed interview 
data with codes that described the essence of the participant’s meaning.  The researcher 
also created a codebook that consisted of a list of all of the codes used during the analysis 
process and a description or definition for each code.  Creating a codebook enabled the 
researcher to code consistently throughout the transcriptions.    
Following the coding, the researcher entered into the third phase of data analysis: 
creation of categories. She analyzed similar segments of data for ways in which to link 
the codes.  The goal of this part of the process was for the researcher to be able to “make 
sense of the experience of all people in all categories in the study, or explain the 
conditions under which exceptions occur” (Green et al., 2007, p. 548).  Lastly, the 
researcher completed the data analysis process by identifying themes that emerged from 
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the data.  It was the goal of this researcher to provide a transparent and detailed account 
of the data analysis process that will provide insight into how the conclusions were 
determined and to establish credibility for the research’s findings.  
Summary 
This chapter described the specifics of a research study conducted for the purpose 
of understanding OB/GYNs’ perspectives and experiences about immunization and the 
meaning they derived from vaccines and vaccination.  In this chapter, the researcher 
outlined her rationale for using a qualitative, phenomenological approach as a way to 
explore the meaning immunizations held for OB/GYNs.  She described her theoretical 
approach and her strategies to establish credibility, including the use of reflexivity and 
bracketing, member checking, and an audit trail.  She listed her qualifications as a 
researcher and described the methods she used to protect the participants’ rights.  In this 
chapter, the researcher also outlined the strategies and procedures she used to identify and 
select participants, and detailed how she managed the collection of data.  Lastly, the 
researcher outlined the process she used to analyze the data generated from the study.  
The researcher will present findings associated with the study in the chapter that follows.  
CHAPTER 4:  FINDINGS 
 
Thirteen OB/GYN physicians from a variety of private practices voluntarily 
agreed to participate in this qualitative study.  Participants were currently licensed and 
practicing OB/GYNs who offered a range of immunizations to their patients.  Participants 
completed one in-depth, open-ended interview with the researcher that lasted between 30 
minutes and one hour.  Participants practiced medicine in various areas of North 
Carolina, including Cary, Charlotte, Fayetteville, Greenville, Hickory, High Point, New 
Bern, Pinehurst, and Raleigh.   
 Data collected from the in-depth, open-ended interviews provided a description of 
the perceived and defined roles of obstetrician-gynecologists in terms of immunization-
related patient education provision and vaccine administration.  The data also provided a 
rich description of the meanings that study participants assigned to the practice of 
immunizing.  In addition, the data revealed some of the influences that impacted the 
OB/GYNs’ immunization practices for adolescents and adults.   
An analysis of the data obtained from the OB/GYNs reveals four primary themes 
and subthemes in their experiences with immunizations.  These themes include the 
vaccination experience, role inconsistency, multiple barriers to providing immunizations, 
and the decision to immunize.   Chapter 4 will explore these themes and describe the 
participants’ perceived and defined role with immunizations, the meaning they assigned 
to the practice of immunizing, and the influences that have impacted their immunization 
practices.   
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Practice Characteristics 
The 13 physicians interviewed represented a wide range of OB/GYN practices 
with a cross section of size, service offerings, and patient characteristics.  Over half of the 
study participants affiliated with medical practices with five or more physicians.  Tables 
1 and 2 display the size of the practices for those interviewed, by number of physicians 
and by number of patients. 
Table 1.  Practice Size (Physicians)  
 
 Single 
Provider 
Office 
Between  
2 and 4 
Physicians 
Between  
5 and 7 
Physicians 
8 or more 
Physicians Unknown 
Number of  
Practices 2 2 6 2 1 
 
The participants used a variety of ways to describe the number of patients for their 
practice.  Some indicated the number of active patients or total number of patients; others 
identified the number of patients per provider or the number of deliveries per month.  The 
table below shows the range of responses for each way they described their practice’s 
size and the number of participants who responded for each category (some participants 
described their practice size in more than one way).   
Table 2.  Practice Size (Patients) 
 Active Patients Total Patients 
Patients per 
Provider Deliveries 
Range of 
Responses 
2,500-4,000 
 
6,500-60,000 
 
20-25/day to 
4-5,000/year/provider 
 
50-60/month 
to 120/month 
 
Number of 
Participants 
Responding 
in this 
Manner 
2 6 4 5 
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With regard to services, all but one participant worked in general OB/GYN 
practices that provided routine obstetric and gynecology services.  The participant who 
did not work in a general OB/GYN practice worked instead as a specialist whose focus 
was on providing consultation services related to high-risk obstetrics and genetics.   
With regards to services, several of these participants mentioned additional 
services their practices offered outside of traditional obstetrics and gynecology.  These 
services included infertility, bone density screenings, cancer treatment, surgery, and 
limited cosmetic services, such as hair removal.  One practice also served as a site for 
clinical trials.    
The patients served by the interviewees also varied by practice.  All of the 
participants reported seeing a wide age range of patients, from pre-teenage years 
(between nine and eleven years of age) to the late 80s and 90s, with the majority of 
patients falling between 18 and 65 years of age.  The youngest reported patient was two 
years old and the oldest was 99 years.  The racial and ethnic demographics for their 
patients also varied.  The participants reported patients’ race/ethnicity as Caucasian, 
African American, and Hispanic in proportions of 30% to 85%, 10% to 60%, and 5 to 
15% respectively.  
Table 3 displays the insurance status of the patients served by the participants.  It 
provides both the range of patients for each category of insurance seen by the 
participants’ practice and the number of participants’ practices that mentioned accepting 
various insurance types. The participants most commonly accepted private insurance, 
followed by Medicaid and Medicare.  
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Table 3.  Insurance Status of Patients 
 
 Medicare Medicaid Private Self-Pay Tri-Care 
Range of Patients 5-40% 10-70% 30-95% 5-15% 5-15% 
Number of Practices 
Accepting Insurance 9  12  13  7  3  
  
The participants also varied in estimating the percentage of women in their 
practices that considered them to be their primary care provider, with estimates ranging 
from 0 to 80% of their patient population.  Table 4 below provides a summary of these 
findings.   
Table 4.  Patients Considering OB/GYN Primary Care Provider 
Percentage of Patients 
Considering OB/GYN 
Primary Care Provider 
<10% 10-30% 31-50% 51-70% 71-90% 
 
>91%
Number of Practices 1 5 1 4 2 0 
 
The participants represented practices that ranged in size from single-provider 
offices to multiple-provider offices with up to nine OB/GYNs in the practice.  All of 
those interviewed were members of American College of Obstetrics and Gynecology 
(ACOG).  The practices varied in the number of patients served from 2,500 to 4,000 
active patients per year.   
The study participants reported serving a wide age range of patients but primarily 
women of reproductive age (18 to 50 years).  The racial and ethnic demographics of 
patients served within their practices also varied but were primarily Caucasians, followed 
by African Americans, Hispanic, Asian, or other.  When describing their patients’ 
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insurance status, almost all participants’ practices accepted Medicaid, and private 
insurance.  
Participants perceived that up to 80% of their patients considered them to be their 
primary care providers, and described their average patients as reproductively active 
women under age 50 years who were relatively healthy and without major chronic 
illnesses.  Participants commonly referred their patients over age 50 years to primary care 
providers such as family practitioners or internists in order to enable those physicians to 
more effectively address any developing chronic disease care issues.   
Vaccination Experience 
  Patients visiting any of the participants interviewed would have a vaccination 
experience that was unique to the provider they were visiting.  Every aspect of the 
vaccination experience could vary, including assessment of immunization status, type of 
visit in which vaccines were discussed, specific vaccines recommended and available at 
the practice, and vaccine-related educational information or materials provided by the 
physician, depending on who provided the health care service within the practice and 
which practice they were visiting.  Presented below are findings relating to each aspect of 
the vaccination experience.   
Assessing Patients’ Immunization Status 
The participants described several ways in which they assessed their patients’ 
immunization status.  Most relied on the vaccine history provided by the patient during a 
verbal interview.  Participant E described his process of addressing immunization history 
with his patients.  “Usually during the course of the interview, I’ll identify and then ask 
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questions.  I don’t have a form that they fill out.  A lot of times it’s just based on [what] 
they will ask me.”  Only a few of the participants mentioned using a specific document 
that systematically addressed questions about the patient’s immunization status.   
The participants also described their practice of regularly assessing the 
immunization status of all of their pregnant women with regards to the rubella vaccine.  
Participant N described the process at his office: “Yeah, with pregnancy, you know, we’ll 
test their rubella status on all the pregnant women to make sure their MMR vaccine they 
got as a child, at least the rubella status, is up-to-date.”  In addition, the participants 
mentioned that they were required to screen the pregnant women for hepatitis B virus 
infection.  While this screening did not inform the OB/GYN about the patient’s 
immunization status, it did tell them if the woman currently had an acute or chronic 
hepatitis B infection.        
None of the participants reported requesting or requiring their patients to provide 
immunization records. Very few participants reported having ever seen a patient’s 
immunization record.  In addition, none of the participants mentioned starting an 
immunization record for their patients.  While this study did not inquire about the 
frequency with which participants assessed their patients’ immunization status, the 
participants seemed to focus primarily on their pregnant patients when they assessed 
immunization status.   
Opportunities to Discuss Vaccines  
The specific points of contact in which the participants discussed immunizations 
with their patients differed.  The interviewees identified four main points of contact with 
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their patients during which the topic of vaccines did or could come up: the annual 
examination visit, the visit for preconception counseling, the first obstetric visit, and the 
six-week post-partum visit.   
The annual examination was the most frequent point of contact mentioned by the 
participants during which they did or could discuss immunizations.  The immunizations 
that they discussed during this opportunity largely depended on the age of the patient and 
the vaccines offered by the physician’s office.  For women under the age of 26 years, the 
participants frequently mentioned discussing the HPV vaccine during the annual visit.  
Some participants described taking this opportunity to also educate these patients about 
their need for Tdap or influenza vaccines.  For women over the age of 50, participants 
most commonly mentioned discussing influenza and pneumococcal vaccines during the 
annual exam.  Participant V described what happened in his practice during the annual 
exam, which exemplified what other physicians described:     
When they’re in for their annual exam, I ask them if they have any problems, are 
they having any concerns, then we’ll do the exam and we’ll sit down and talk 
about lifestyle, healthy habits, risk factors, and any vaccines that they need. So, 
we kind of do it at their annual, once a year visit. 
This annual visit for their non-pregnant patients was one of the main opportunities the 
participants identified to discuss needed vaccines with their patients.   
Only a few of the participants identified the preconception-counseling visit as an 
opportunity to discuss immunizations with their patients.  During the preconception visit, 
providers who viewed this visit as an immunization discussion opportunity, tended to 
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address rubella and influenza vaccines.  Only one participant mentioned using this point 
of contact as an opportunity to discuss the Tdap vaccine with the women.   
 Participants also identified the first obstetric visit as a time to discuss 
immunizations with patients.  They described talking with patients about a need to assess 
rubella antibody titers and hepatitis B infection during this visit.  If the first obstetric visit 
(or any subsequent visit) occurred during the flu season, multiple participants stated they 
would use these opportunities to recommend the influenza vaccine to their patients.  Only 
one participant reported discussing the recommended post-partum dose of Tdap with 
pregnant patients.   
The six-week post-partum visit was another opportunity identified by the 
participants to discuss immunizations.  However, only a few of them recognized this as 
an opportunity.  The few who did identify it as a potential point of contact, agreed that it 
was a good time to discuss influenza and Tdap immunizations.  
The majority of participants were aware of some, but not all of the opportunities 
they had in which to discuss immunizations with the women they served.  The 
participants named the annual exam most frequently when discussing the opportunities 
they had to talk about immunizations with their patients.  While this study did not 
formally assess the frequency with which they actually took these opportunities to discuss 
vaccines, the participants seemed to utilize the annual exam most often.  
Vaccines Recommended & Available 
 The vaccination experience described by the participants had the greatest amount 
of variability when the discussion turned to which vaccines they recommended and 
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offered their patients.  Of the 13 physicians interviewed, one offered no vaccines due to 
this provider’s primary role as a consultant specialist; seven offered between one and 
three vaccines; and five offered four or more vaccines.  Table 5 displays the vaccination 
practices of the participants.   
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Table 5.  Vaccination Practices 
 
Vaccine Available in Office 
Not 
available, 
but will 
write 
prescription 
or order 
Not available, 
but would 
recommend and 
refer to another 
doctor 
Not 
available, 
no 
discussion 
Other 
Influenza 11 0 1 0 
1 – hospital-based 
practice and refers 
patients to hospital 
flu clinic 
HPV 10 1 1 1 0 
Rubella  
(MMR or single-
antigen) 
6 0 
1 recommends; 5 
recommend but 
rely on hospital 
to provide 
0 1- unsure 
Tetanus  
(Td or Tdap) 5 3 
2 recommend but 
rely on hospital 
to provide 
3 0 
Hepatitis A 1 (Hep A/B Combo) 1 2 7 
2 – considered but 
decided not to offer 
because of cost 
Hepatitis B 
3 Hep B;  
1 Hep A/B 
combo 
1 2 4 
1 – used to but 
stopped; 1 – only 
for employees 
Meningococcal 0 1 3 9 0 
Shingles 2 1 0 9 1 – researcher did not ask 
Pneumococcal 2 1 2 5 3 – researcher did not ask 
 
Summary of Vaccination Practices 
Influenza.  Influenza was the vaccine most commonly offered by the participants 
to patients seen in their OB/GYN practices.  The participants’ primary target for this 
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vaccine was pregnant and elderly patients, although some also strongly encouraged their 
patients at high-risk for complications from the disease to become immunized against 
influenza.  Patients who were not pregnant or who did not fit into a high-risk category 
also had the option of receiving the influenza vaccine at their practices, but the vaccine 
was only available on request.  One of the participants provided the influenza vaccine 
only for obstetric patients.    
HPV.  The HPV vaccine, Gardasil, was the second most commonly offered 
vaccine among the participants.  They seemed to embrace this vaccine and many reported 
promoting it heavily among their young women patients who were eligible to receive it.  
Multiple participants also reported advocating for the vaccine beyond their own patients 
by talking to mothers of girls old enough to receive the vaccine.  The participants who 
did not offer the HPV vaccine did so primarily because of cost incurred by them to store 
and administer the three-dose vaccine.   
Rubella.  Some practices used the single-antigen vaccine while others gave the 
combination measles, mumps, and rubella (MMR) vaccine.  The majority of participants 
interviewed described discussing MMR vaccine with women during preconception 
counseling and testing for rubella immunity among pregnant women.  Those who did not 
provide it in their offices tended to rely on the hospital to provide the vaccine post-
partum to women who needed it.  The participants seemed to be committed to discussing 
this vaccine during preconception and screening during pregnancy, and vaccinating 
women themselves or at least working with the hospital to ensure the vaccination of the 
susceptible women.   
59  
 
Tetanus.  Immunization practices regarding the tetanus-containing vaccines of Td 
and Tdap differed greatly by practice.  Even the act of discussing the vaccine varied 
among participants: a few participants mentioned discussing the vaccine with women 
during preconception counseling, while others talked with patients about it during the 
annual exam, and still others mentioned it to women during the six-week post-partum 
visit.  Several did not report discussing this immunization with women.   
Hepatitis A & B.  The vaccination practices regarding the hepatitis A and B 
vaccines also varied by practice.  For hepatitis A, only one practice offered the vaccine, 
and it was in the form of Twinrix, the combination hepatitis A/B vaccine.  A few had 
considered offering the vaccine; one participant would order it if needed; and a few 
others recommended but did not administer it.  Outside of these providers, participants 
did not offer or discuss hepatitis A vaccine.   
Hepatitis B vaccine was available in more of the participants’ offices.  When 
discussing this vaccine, the participants were more likely to mention the required 
screening they had to complete for all pregnant women than the vaccine itself.   
Meningococcal.  None of the participants interviewed offered meningococcal 
vaccine, and only a few recommended it to their patients.  Some participants explained 
their rationale for not providing this vaccine by pointing to the low numbers of eligible 
recipients that they see.  Other participants cited a reliance on pediatricians or family 
physicians to provide this vaccine.   
Shingles & pneumococcal.  Only two of the participants’ practices offered 
shingles vaccine to the women over the age of 60 years in their practices.  Two 
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participants’ offices provided the pneumococcal vaccine to the post-menopausal women 
they served.  When asked about these vaccines, only a few physicians indicated that they 
recommended them to their elderly patients.  Many stated that they tended to rely on 
other primary care physicians, such as internists or family practitioners, to recommend 
and provide these vaccines.   
Overall, the immunizations recommended and provided by the participants varied 
greatly by practice and by vaccine. HPV and influenza were the vaccines most commonly 
offered by the participants, while meningococcal, hepatitis A, shingles and pneumococcal 
were least frequently provided.     
Educational Materials Offered  
The educational focus and materials provided as part of patients’ vaccination 
experiences at participants’ practices also varied.  While all of the participants who 
offered vaccines reported the availability of some type of educational materials, the 
immunization information they offered was limited to HPV and influenza vaccines.  One 
participant described offering a pre-recorded walkman to patients that explained the HPV 
vaccine and its purpose.  Participants most commonly reported using brochures and 
pamphlets as patient educational materials and those materials were generally limited to 
the HPV and influenza vaccines.    
Information about other vaccines was scarce.  A few reported using immunization 
educational materials provided by ACOG; however, several mentioned that these 
materials were not offered free of charge and that cost impacted availability of such 
materials for patients.  Others indicated that they would go to the CDC or ACOG website 
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to print information for their patients about vaccines if their patients expressed a need or 
desire for it.  
When asked if they perceived a need for additional educational materials, all but 
two of the participants said they had no such need.  Of the two who indicated a need, one 
wanted an easy-to-understand adult immunization schedule they could share with 
patients.  Another wanted more information about meningococcal vaccine.  Providing 
immunization educational materials did not seem to be a primary concern or focus for the 
study participants. 
Most of the participants described providing an informational packet or bag to 
their new obstetric patients that included information about pregnancy, delivery, and their 
child.  For all but two of the providers, these packets contained no immunization 
information.  Of the two who provided immunization information, one provided 
information from Baby Love, the Medicaid program for pregnant women in the State of 
North Carolina, which has vaccination information included within it.  The second 
participant provided a DVD about pregnancy that included vaccine information.  All of 
the participants agreed that the OB packet or bag offered an opportunity to provide 
vaccine information to their obstetric patients.   
In general, the educational materials provided by participants about 
immunizations focused on the HPV vaccine.  Beyond that, information was largely 
lacking and the participants did not seem particularly concerned about or interested in 
providing such information.   
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Summary  
For any given patient of the providers who participated in this study, the 
vaccination experience could vary in a number of ways.  Every aspect of the vaccination 
experience differed among participants, including assessment of immunization status, 
type of visit in which participants discussed or offered vaccines, specific vaccines 
recommended and available at the practice, and educational materials provided by the 
physician.      
Vaccination experiences within the practice could vary, depending on the 
physician from whom the patient was seeking treatment.  Several participants pointed out 
that, although the practice might decide to provide a specific vaccine, not every physician 
within that practice would encourage, recommend, or even provide it in the same fashion.  
As Participant K explained, “Everybody offers many of the same things, but I don’t know 
if all of the same things are emphasized by each individual as much as others.”  This 
variability among practices and among providers illustrated the inconsistency and the 
variety of vaccination experiences that could occur within and between the participants’ 
medical practices.   
Role Inconsistency 
   There was little agreement among how participants defined their roles associated 
with primary care, immunization provision, and patient education about vaccines.  Some 
participants defined their roles quite broadly and included a variety of responsibilities, 
while others took a more narrow approach and defined their role based on the population 
they served. Such differences were also apparent in how participants defined their scope 
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of work. Presented below are findings relating to participants’ perceptions about their 
roles.   
Role as Primary Care Providers 
When discussing and defining their roles in terms of primary care provision, the 
participants described one of two scenarios: they saw themselves either as a primary care 
provider or as a specialist who had limited primary care responsibilities.  While they 
agreed on which patients were most likely to consider their OB/GYN to be their primary 
care provider (i.e., relatively healthy, reproductively active women under the age of 50), 
they disagreed as to what types and level of services they should be providing while 
serving as a primary care provider.   
Some participants described an extensive role for OB/GYNs with primary care.  
As Participant D explained,  
Since we have been given that title as being a primary care provider, I think we 
need to take responsibility and do the things that go along with that primary care, 
not just vaccines, but routine labs, checking cholesterol, thyroids and diabetes - all 
the things that go along with preventative medicine.  We need to remain up-to-
date on what the recommendations are and recommend them for our patients.   
Participant J agreed with this more broadly defined role, and believed it was the 
responsibility of providers “to make sure you’re covering all aspects of their health care 
and not just their reproductive health.”  The participants who saw themselves as having a 
larger role in primary care also recognized that many of their patients did not have 
another doctor for their health care needs.   
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 Not every participant agreed with or wanted to have a more comprehensive role 
as a primary care provider.  Participant H struggled with this issue, for he knew he was 
serving as a primary care provider for some of his patients, but did not feel that he was 
the best-qualified physician to provide such care.  As he explained,            
I think that my reluctance to do primary care is just because I don’t think it’s in 
the patient’s best interest for me to do it… It’s like; I don’t think a family 
practitioner should be doing c-sections.  They don’t know what they’re doing.  
And I have to say, am I the best person to give this person information?  Do I 
know the most about it?  Do I know the ins and outs of as well as someone else 
and I have to be honest and say, no I don’t. 
Some of the participants indicated that they would prefer that another physician 
handle the bulk of the primary care duties, while others felt comfortable providing limited 
primary care services, but only for women who were relatively healthy.  The participants 
who saw themselves as having a more limited role in primary care commonly expressed a 
desire to share responsibility with other providers for their patients’ health care needs.  
The participants divided almost evenly in how they defined their role with primary care, 
with six providers describing a broader, more involved role with primary care, and seven 
providers describing a narrower, more focused role.   
Immunization-Specific Role 
 The ways in which they defined their roles with immunizations was another way 
in which the participants differed.  Some defined their role based on whether or not the 
patient considered them a primary care provider.  Others defined their roles for either a 
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specific vaccine or population.  There did not appear to be a relationship between the way 
in which the participant defined their role with vaccines and the number of vaccines 
offered.  For example, some participants who described a very limited role for themselves 
with vaccines also came from practices that offered four or more vaccines.   
Six of the participants defined their roles with immunizations in terms of whether 
or not their patient considered them a primary care provider. For these patients, they 
acknowledged playing a role in both recommending and providing necessary vaccines.  
As Participant Y explained,  
It [his role with vaccines] would really be dependent on the patients needs.  If this 
is someone that you really are that primary care provider for, then you need to 
educate and vaccinate.  If this is someone that you’re touching in life and they 
have a primary care provider, then I see my obligation as making sure that 
primary care provider is aware of what the recommendations are, and they would 
be the one to actually administer it, but I would be a patient advocate that they 
know to seek this.   
The participants who defined their role in this way felt responsible for vaccine provision 
because they recognized that their patients might not have another doctor or might not go 
elsewhere to receive the vaccine.  
For women outside of the primary care window of age 18 to 50 years, the 
participants saw themselves playing a lesser role in vaccine provision.  They seemed 
much more willing to refer these patients to pediatricians, family physicians, or internists, 
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as appropriate.  As Participant S explained, he focused on women between 20 and 50 
years of age:  
People don’t really need pap smears until they’re 20ish, unless they are sexually 
active.  So, we’re seeing some kids for menstrual problems and those, they 
typically have pediatricians, so we let them [pediatricians] deal with that.  So, the 
OBs role is going to be the 20 to 30 to 40 year olds, just keeping them healthy and 
happy.  Once people get 50, 60, if they truly haven’t had another doctor, then I 
urge them to get a primary care doctor, just for some older age screenings.   
The greatest amount of disagreement among the participants who defined their 
role with immunizations in this way came for those ‘bubble’ patients – either their 
adolescent patients under the age of 18 years or adult patients over the age of 50 years.  
Some participants believed their role was to serve as a counselor or advocate for 
immunization among these age groups, making recommendations to those patients who 
needed vaccines but not administering vaccines to them. Others felt they were 
responsible for providing necessary vaccines to these patients.   
 Despite a belief that they had a role to play in immunizing patients who 
considered them primary care providers, many of the participants did not have available 
all of the vaccines recommended for these women.  When asked to explain this 
discrepancy, many of the participants could not offer an explanation.  Some seemed to 
realize that how they defined their role with vaccines did not match their immunization 
practices, and a few vowed to “look into” providing the vaccines that they were missing. 
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While approximately half of the participants defined their roles with 
immunizations based on whether or not they were the patient’s primary care provider, the 
remaining participants defined their role with immunizations more in terms of their 
responsibilities relating to a specific vaccine or population group.  For example, 
Participant A defined his role with vaccines as follows:  
I think that with Gardasil, OB/GYNs should be probably at the front line of giving 
it to patients.  The flu shot I see as second line, primary care doctors should be 
pushing that… Probably everything else is a distant third.   
Of the participants who defined their roles this way, many also focused 
specifically on their role with the HPV vaccine.  As Participant F explained, “I think 
primarily for women’s health issues, our role is really the HPV vaccine.  That really falls 
under our area more than any of the others.”  They saw the HPV vaccine as fitting within 
their scope of practice more than the other vaccines, and often expressed a strong interest 
in the vaccine because of its potential impact on cervical cancer, a health issue that falls 
directly into their scope of practice. Participant F explained his perspective on other 
vaccines:  
Where, you know, the flu vaccine, I do what is recommended by the CDC, I don’t 
have any real, there’s no passion there, there’s no passion there for any of the 
other vaccines, frankly.  You just do what’s recommended, basically.  Or, you 
make sure they go to a place that does those things, that follows those 
recommendations.   
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These participants felt that the HPV vaccine strongly tied to their professional 
responsibilities, and saw less relevance for the other vaccines.  
Other participants defined their role with vaccines more in terms of the population 
groups that they served.  They saw a role with their obstetrics patients, in particular.  As 
Participant R explained, “I guess our emphasis is primarily for the vaccines associated 
with obstetrics and the other vaccines I think are received other places, or received from 
the pediatricians.”  Participant H took this idea one step further, and defined his role with 
vaccines for women before, during and after pregnancy.  The participants clearly 
identified pregnant women as their specialty, and were more than willing to provide 
vaccines recommended for this group.  A willingness to discuss vaccines during 
preconception and post-partum patient visits varied among the participants.  
A clearly defined role with vaccines other than influenza and HPV or with patient 
populations other than pregnant women may be lacking for many of these participants.  
They may not have formalized or even thought too much about how they define their 
relationship with vaccines. Regardless of how they defined their role with vaccines, 
whether it was in terms of their primary care relationships or by vaccine and population 
group, all of the participants interviewed saw themselves as vaccinators to some degree. 
Role with Educating Patients 
All of the participants agreed that they had a role to play with educating patients 
about vaccines.  Even if they did not have the necessary vaccines available in their own 
medical practices for administration to their patients, many believed that they should be 
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current on the issue of vaccines, able to talk about them with patients, and recommend 
them if needed.  As Participant K explained,  
Certainly there’s a role for that [being an educator], you know, I think if you’re 
going to be giving vaccinations out, you can’t give them out blindly – you’ve got 
to be an educator of some kind.  I think if you were not administering vaccine, I 
think it’d still be incumbent on you to educate your patients about it.   
This role as an educator about vaccines was one of the few areas of immunizations on 
which all of the participants agreed.  In addition, they all believed they were already 
fulfilling this role adequately as part of their normal physician duties.   
Scope of Work 
 In addition to expressing differences in how they defined their role in terms of 
being a primary care provider and consequent provider of immunizations, the participants 
disagreed about where vaccines fit within their scope of work.  Almost half of the 
participants saw vaccines fitting with their routine screening, prevention, and primary 
care scope of duties.  These participants included those who offered between one and 
three vaccines and those offering four or more vaccines.  As Participant A explained, 
 I think that it [vaccinating] should be a part of the preventive care business that 
we do every year.  It’s not the first thing we want to discuss but it’s part of routine 
screening and preventive maintenance, and that’s where it fits in.  
Other OB/GYNs reiterated that vaccines were not high on their priority list.  
Participant E provided a breakdown of the vaccines he considered within his scope of 
practice, by age of patient:  
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I would say for me, my number one issue for patients over 50 is hormones, 
menopause, then it’s breast health and bone health.  I would say vaccines are 
probably down towards the bottom of the list on my priority when I’m taking care 
of patients over 50.  In my younger patients, my under 26-year-olds, its right up 
there with abnormal pap smears, contraception, vaccination.  My pregnant 
patients, it’s right up there.  Pneumococcal, shingles – that’s way down the list of 
priorities.  
While these participants agreed that vaccines fit within their primary care scope of work, 
they disagreed about the fit of specific vaccines.  Participants identified HPV, influenza, 
and possibly rubella as the vaccines that most likely fit within the OB/GYN scope of 
work.  Other participants believed that vaccines other than HPV and influenza were 
outside of their scope of work.  As Participant H described it,  
Those [vaccines] are probably… more in the periphery in what I feel like my 
responsibility is.  I mean, cervical cancer, that’s sort of the realm of the OB/GYN 
and just like, when you’re pregnant, your responsibility is the health of that 
pregnant woman.  Where as, we probably feel more like specialists… in other 
areas.  I sort of feel like when I see somebody; my main responsibility is to do 
their pap, to do their breast exam, and to talk about birth control.  I probably feel 
like it’s somebody else’s responsibility to talk to them about other things, and so 
I’ve kind of viewed the, something like shingles or meningococcal… [as] maybe 
not quite as important.   
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How broadly they perceived their role in primary care and with immunizations seemed to 
relate to how they saw vaccines fitting within their scope of work.   
Summary 
The participants expressed differing opinions when defining their role with 
primary care and consequently with providing immunizations.  Some envisioned their 
immunization roles as comprehensive and inclusive, while others took a more narrow 
approach and defined their role based on a specific vaccine or population.  Participants 
agreed that they played a role in serving as educators to their patients about vaccines but 
the identification of vaccines that specifically fit within their scope of work differed 
among them.  These disparities among the participants illustrate the inconsistency that 
participants’ faced when defining their role in the areas of primary care and 
immunizations.     
Multiple Barriers to Immunizing 
All of the participants agreed that they faced multiple barriers to patient 
immunization.  They identified four main barriers to immunization: cost, logistics, patient 
knowledge, and provider knowledge.  Findings from data related to immunization 
barriers are below.   
Cost 
Almost every participant identified cost as a barrier to providing vaccines.  The 
discussion on cost revolved around three main concerns: the cost to the practice to keep 
the vaccines in stock, including the level of insurance reimbursement to the medical 
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practice; the amount of staff time associated with vaccine administration; and the cost to 
patients.   
Cost to practice.  Most of the participants described the cost to the practice as a 
barrier to providing vaccines.  Many stated that their practice lost money as a result of 
providing vaccines.  The cost issue seemed centered on reimbursement.  As Participant V 
described, “Reimbursement’s the issue.  A lot of the vaccines we can’t get reimbursed 
what it costs us to get the vaccine, let alone on the needles and the syringes and the staff 
time to give it.”  The participants felt they had little incentive to offer the vaccines 
without reimbursement for the cost of the vaccine and for the staff time to administer it.  
However, they also stated they were not concerned about making a profit from 
vaccination; they just wanted to be able to break even and stop losing money.    
Another issue with reimbursement that several participants identified was the 
perception that primary care providers such as family physicians received reimbursement 
differently or at higher rates for some services such as vaccination.  Participant H 
observed, “And some of this stuff interestingly, like it’s covered if you [patient] do it at 
your primary care doctor[’s office], but it’s not if you do it at your OB/GYN[’s] office.”  
While this study did not assess the specific cost to the practice and the reimbursement 
rates, the participants felt this was a major barrier to immunizing their patients.   
To combat the reimbursement issue, several of the participants’ practices had 
resorted to writing prescriptions so they did not have to pay the money up-front to stock 
the vaccines.  Others stated that they were considering doing that in the near future.   
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Staff time.  The participants also identified the amount of staff time required to 
handle the logistics of vaccine administration as a cost-related barrier.  The time required 
for nursing staff to track down the reimbursement rates, fill out the appropriate forms, 
and administer the vaccines cost their practices valuable staff time.  Participant H 
explained his frustration with this cost barrier:  
I think a lot of patients almost expect us to know whether or not it’s covered on 
their insurance and if we don’t, then they want us to track down that information.  
That’s probably a third of our staff already is working in just dealing with the 
insurance company and so, we don’t have the man hours, or the manpower to do 
that.   
The participants considered staff time to be a valuable asset to the practice and perceived 
inadequate compensation for the time spent handling the logistics of administering the 
vaccines.  
Cost to patients.  Several participants identified cost to patients as a barrier to 
providing vaccines.  They described patients who were eligible to receive the vaccine, but 
who could not afford to do so, or who would not pay the out-of-pocket cost for the co-
pay.  Even patients with insurance, including those covered by Medicaid, would 
commonly refuse to pay out-of-pocket costs for vaccinations.  Participant V described 
this trend, “A lot of patients don’t even want to pay the co-pay, like Medicaid patients, 
for some of the vaccines, it’s like a $3 co-pay and they don’t want to pay it.”  Several 
physicians expressed frustration that their patients would not take the vaccines.   
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In summary, for some patients, the participants believed that cost, no matter how 
small, was a major barrier to receiving vaccines and cost was a major barrier in providing 
vaccines.  Practice-related costs included limited insurance reimbursement and staff time. 
Logistics 
Participants identified the logistics associated with providing vaccines as major 
barriers to immunization.  The logistics they identified included such issues as assessing 
immunization status, ensuring availability of vaccines, handling multi-dose vaccinations, 
coordinating storage and handling, and time required to educate patients about vaccines.  
Determining immunization status.  Several participants described the difficulties 
they faced in determining which vaccines were needed by the women they served within 
the allotted time they had to see patients.  Participant F’s experiences revealed that most 
adults either did not know or assumed that their immunizations were up-to-date.  Study 
participants identified difficulties assessing a patient’s immunizations status as a barrier 
to providing vaccines.  Participant Y, for example, believed that assessing patient 
immunization status warranted improvement, and wanted a better way to be able to check 
the immunization status of his patients such as a data bank or immunization registry.      
Availability of vaccines.  Simply accessing vaccines was another logistical barrier 
identified by several participants.  Participant A talked about his difficulty in finding the 
shingles vaccine.  Other doctors remembered problems in finding the influenza vaccine 
several years ago.    
Multi-dose immunizations.  Vaccines given in a series, such as hepatitis B or HPV 
also presented logistical barriers for the participants.  Getting the patient back into the 
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office for a subsequent vaccination could be difficult and follow-up for the second and 
third doses of theses vaccines was problematic.  As Participant E described it, “the other 
barrier would be the multiple dosing vaccines.  To get patient compliance, they hurt 
[from the immunization], they don’t want to come back.  It surprises me how many 
people don’t do the full three doses of Gardasil.”   
Storage and handling.  In discussing logistical barriers, a few of the participants 
identified issues relating to the storage and handling of vaccines.  These included issues 
such as keeping the vaccines in stock, monitoring expiration dates, and maintaining an 
adequate supply of vaccines.  Some participants felt this barrier would only increase as 
their practices expanded their immunization offerings.  Participants whose practices 
offered between one and three vaccines primarily identified these storage and handling 
concerns.  None of the participants associated with practices that offered four or more 
vaccines named storage and handling as a barrier.   
Available time.  Several participants identified time as a logistical barrier to 
vaccine education and administration. They described having a limited availability of 
time with their patients to cover everything they needed to discuss. Some of the 
interviewees felt that the amount of time it would take to discuss the vaccines with their 
patients was a significant barrier to vaccination.  As Participant H explained,  
For most people it’s probably not as easy as just saying, ‘alright, you need a 
tetanus shot.’  There’s going to be questions of – well, why do I really need this?  
How safe is it for me?  And, is it going to be covered by my insurance?  And, 
those are just, I think that unfortunately sometimes it just opens up a whole can of 
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worms, that you may not have time or expertise to really answer a lot of these 
types of questions.   
As Participant H suggested, many participants found a time-related logistical barrier to be 
taking the time to identify vaccines the patients needed and discuss with patients the 
benefits and costs associated with them. 
The logistics of providing vaccines, including assessing immunization status, 
ensuring availability of vaccines, handling multi-dose vaccinations, coordinating storage 
and handling, and taking the time required to educate patients about vaccines were all 
barriers to providing vaccines.  Participants associated with practices that offered 
between one and three vaccines identified far more logistical barriers than their 
counterparts who offered four or more vaccines.   
Patient Knowledge & Misconceptions about Vaccines 
A majority of the participants interviewed, including all of those who offered four 
or more vaccines, identified patient knowledge or misinformation and fear as a barrier to 
providing vaccines.  This barrier included issues such as patients’ fear that the vaccines 
might harm them or their fetus, fear that the HPV vaccine might promote sexual activity 
in their children, and lack of knowledge that they needed the vaccine.   
Fear that the vaccine might cause harm.  Multiple participants reported having to 
overcome patients’ misconceptions about vaccines, such as the belief that the vaccine 
would make them sick or harm their child.  Participant V explained his experiences with 
this barrier, “Patients are afraid of them [vaccines], you know? They [think the vaccines] 
cause birth defects, mental retardation, they [think they will] get sick from them, [that] it 
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doesn’t prevent infections, so that’s one big barrier.”  Fear that the influenza vaccine 
would make them sick or that getting vaccinated while pregnant would harm the fetus 
was a barrier that multiple participants said arose while discussing vaccines with their 
patients.  
Participants believed that patient fears may in part stem from the fact that many 
women under the age of 50 years have not experienced any of the diseases that vaccines 
commonly prevent.  Instead of focusing on the benefits of vaccines in disease prevention, 
participants believed that patients who were unfamiliar with the vaccine-preventable 
diseases might focus instead on the potential negatives of the vaccines, such as the side 
effects.   Participants cited their patients’ lack of informed perspective or respect for the 
disease as another barrier to vaccine administration.  
Several participants also reported expressions of concern among pregnant patients 
that vaccines would cause autism in their unborn children.  Participant J’s practice even 
switched to a thimerosal-free version of the influenza vaccine to help overcome this 
barrier: 
We have a number of patients that, because we deal with the pregnant patients, 
[were] raising concerns about autism and vaccine safety. Especially the pregnant 
patients when it comes to the flu vaccine.  Because the flu vaccine we were using, 
we were using the one that did have a little small amount of thimerosal in it.  A lot 
of the moms raised questions about that and we have switched to the thimerosal-
free vaccine.      
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On probing participants about their response to patient concerns about autism, they 
shared their insights into the problem.  One participant, Participant K, described what he 
would tell his patients about this concern:  
I usually tell them that it looks like the best evidence now is that we’re really not 
100% sure that there’s a direct link between them.  There’s some studies that 
indicate there may be, there’s some studies that indicate that there’s not, and so – 
it’d be nice to know for sure, but we don’t know the answer to that.    
However, other participants addressed this concern by pointing to the fact that no 
research has linked autism with vaccines.  Participant E described what he would tell 
patients concerned about this issue:   
From everything I’ve read, and everything I’ve studied, I see no link of autism 
and vaccinations.  And, if there really was a true, strong link, it would be 
disseminated widely.  I mean, so, the fact that I have not read anything, I have not 
seen anything, it’s highly likely there is no link.   
In summary, several study participants cited the need to address patient concerns about 
vaccines in a timely, accurate, and effective manner as a barrier to vaccine 
administration.   
Concern about risky behavioral outcomes.  Participants identified a patient 
concern about vaccination related to the HPV vaccine.  Participants recalled talking to 
mothers who were concerned that their daughters would view receiving the vaccination 
as permission to have sex.  In response to such concerns, Participant G told patients, “I’m 
not giving you permission to have sex; I’m giving you permission not to have cervical 
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cancer.”  Other participants reported this issue as a barrier to vaccination, and were also 
willing to talk to their patients to try to overcome it. 
Lack of awareness about vaccine need.  Participants identified that patient 
knowledge about their need for vaccines was another barrier to vaccine administration.  
The participants believed many adults were unaware of their need for vaccines, and felt 
they, as physicians, had to take extra time to explain why they needed such vaccines.   
A low frequency of patient demand for vaccines was another patient information-
related barrier.  The participants identified influenza and HPV as the most commonly 
requested vaccines within their medical practices.  However, they reported that such 
requests were infrequent.  Participants typically had to broach the subject of 
immunizations with their patients. 
The participants were able to identify multiple layers of patient information-
related barriers that need addressing in order to immunize more patients.  They believed 
that addressing patient fears about side effects and overcoming misconceptions that the 
public had about vaccine safety were two ways to address this barrier.  In addition, they 
believed that their patients needed general education about vaccines.   
Provider Knowledge  
Almost all participants identified their own knowledge about vaccines as a barrier 
to providing immunizations.  Primary barriers were their ability to remember to 
incorporate vaccine assessment and education into their patients’ routine visits and their 
complete understanding all of the intricacies of vaccines and vaccination.  Additional 
barriers related to provider knowledge included several potentially mistaken beliefs: a) 
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few of their patients needed vaccines; b) their patients were up-to-date with the necessary 
immunizations; or c) other health care providers were giving their patients the vaccines 
they needed.   
Making vaccines part of the routine.  Several participants identified that a barrier 
to immunization was their ability to remember to incorporate vaccinations into the 
routine part of their visit with patients.  They described focusing more on other 
components of the visit or exam that they often simply forgot to talk about vaccines with 
eligible patients or were too pressed for time to bring it up.  Participant J discussed this 
barrier: 
I think OB/GYNs in general, just getting them to think about women’s health 
overall and not just focusing on the pap smear and breast exam.  I mean, you’re so 
constrained in terms of the time that you have to spend with the patient and the 
things you have time to educate the patient about… So, I think, because we have 
so much on our plates, just getting us to think in that frame of mind [is a 
challenge].   
Because participants did not regularly talk about vaccines with their patients, they did not 
view vaccinating as a part of their usual health care practice.   
One participant suggested that overcoming this barrier may require minimal extra 
effort on the OB/GYN’s part.  As Participant H explained, “It’s probably just inertia.  
You don’t really commonly talk about it, so you don’t think about it as much.”  The 
participants believed that if they could incorporate vaccines more completely into their 
routine patient visits, remembering to talk about vaccines would become less of a barrier.   
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Limited vaccine knowledge.  Participants identified their own levels of knowledge 
about vaccinations as a barrier to vaccination.  Participant H was particularly adamant 
about this point.  As he explained it, “my discomfort with it is that I have so much that I 
need to continue learning about just about OB and GYN that it’s hard to sort of keep up 
with the latest recommendations regarding vaccinations.”  He and several other 
participants did not feel completely confident in their current knowledge about the 
intricacies of vaccines and felt that they may not be the best persons to be administering 
them.  They were worried that they did not fully understand all of the potential side 
effects of vaccinations and that offering immunizations might not be in the best interest 
of their patients.  Despite their lack of knowledge about the intricacies of vaccines and 
vaccination, participants who identified this barrier also felt comfortable in their ability to 
overcome it by simply reeducating themselves about the current recommendations and 
vaccination guidelines.    
The participants’ limited knowledge about vaccines did not translate into concerns 
about vaccine safety.  Most stated that they had no concerns about offering vaccines, and 
they all stated that they felt the benefits of vaccination outweighed the risks.  Those who 
did express concerns talked about their worry that vaccines were not truly effective 
(especially the influenza vaccine) and that health experts were not fully aware of their 
side effects, particularly the long-term side effects  
Limited awareness of eligible patients.  The barrier of provider knowledge 
manifested itself in other ways.  The participants often linked their reticence to offer 
vaccines to their perception that only a limited number of their patients were eligible to 
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receive vaccines.  This observation represented a potentially large immunization barrier 
in that many participants did not realize the actual proportion of their patients who were 
not only eligible, but also recommended to receive vaccines.  For example, Participant E 
recognized this as a barrier when he discussed the meningococcal vaccine:   
I guess because I’ve never really linked meningococcal as a vaccine that should 
be [administered to the] total population.  I would not have – in my mind – the 
thought of every college-going female to make sure they had a meningococcal 
vaccine.  I did not realize that that would be – and honestly I can’t say I’ve ever 
given a college-aged [person a] meningococcal [immunization]. 
Perception that patients are up-to-date.  Another barrier related to provider 
knowledge is the belief that all of their patients are current with their immunizations. 
They reported believing that “in theory” everyone who came to see them was up-to-date 
with their immunizations.  Several of the participants admitted, however, that they were 
probably incorrectly making that assumption.  
Assumption someone else is the provider.  The participants often repeated the 
belief that another health care provider was providing the necessary immunizations to 
their patients.  Particularly with the meningococcal, shingles, and pneumococcal 
vaccines, the participants often expressed the belief that their patients could get these 
vaccines at their other primary care providers.  As Participant E explained,  
I guess I just anticipate that that’s someone else’s area – like pediatricians and that 
all should have been done by the time they got to me. And then, once they’re over 
50 – most of them, like I said, most of them I try to make sure they have a family 
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doctor and then I just expect the family doctor to follow up on those other 
vaccines.   
Existing provider knowledge is an immunization barrier that manifests itself in a 
number of ways.  Participants cited not remembering to incorporate vaccines into routine 
patient visits or fully understanding all of the idiosyncrasies of vaccines or vaccinations.  
In addition, they acknowledged the possibility of incorrectly assuming that only a few of 
their patients were eligible to receive vaccines; that their patients were already up-to-date; 
or that someone else was immunizing their patients.   
Summary 
A major theme that emerged from the data in this study was the barriers that 
participants associated with the practice of immunizing.  All of the participants named 
multiple barriers to offering vaccines by them or their medical practice.  Some barriers 
related to more pragmatic issues, such as cost and logistics. Other barriers focused on 
patient and provider knowledge and beliefs.  The multiple barriers that participants 
described illustrated some of the obstacles that they faced when it came to immunizing 
patients in their practices.     
The Decision to Immunize 
Despite the range of vaccination experiences, inconsistently defined roles as 
immunizers, and barriers that participants identified, most of the participants still decided 
to immunize their patients.  The participants’ interpretation of the influences, benefits, 
and meaning of their vaccination practices impacted and reinforced their decision to 
immunize. Presented below are the findings relating to their decision to immunize.   
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Influences 
A number of contributing factors influenced the participants’ decision to 
immunize their patients.  The participants were able to identify three main influences of 
their immunization practices, including ACOG recommendations, prevalence of disease, 
and patient demand.   
ACOG recommendations.  The majority of those interviewed named ACOG’s 
recommendations as a key influence in guiding their immunization practices. These 
recommendations were described as being so important in medical practice that one 
participant mentioned waiting for ACOG to make a formal recommendation about Tdap 
vaccine before administering the vaccine.  As Participant N described,  
That’s why it’s important for us to keep up with the ACOG recommendations and 
stay active in the membership and read all the current guidelines as far as what’s 
recommended by ACOG, because if we do what’s recommended by ACOG, then 
we’re not going to get in trouble with anybody.  It’s just as simple as that, because 
if someone comes to us and says, ‘it’s ACOG recommendations and you didn’t do 
it and now this patient has a problem,’ then yeah, I’m at fault.  If the ACOG 
recommends it, that’s my medical society and I’m supposed to be practicing 
medicine under their guidelines.   
ACOG’s recommendations were very important and influential in their decision-making 
about which vaccines they offered.   
Although many named ACOG as a key influence in their medical practices in 
general and immunization practices in particular, several participants acknowledged that 
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they did not know what ACOG recommended for some vaccines.  As Participant H 
explained,  
Yeah, I’ll be honest; I’m not completely sure what ACOG’s stand on it [some 
vaccines] is…. I know they recommend flu vaccine and I know they recommend 
Gardasil, but I’m not really sure what their recommendations are regarding things 
like shingles or meningococcal or some of the other ones.  Certainly, if I was 
better versed in that, it [vaccination] probably would be more important to me.   
Several other study participants also commented that they probably could not describe 
ACOG’s recommendations for vaccines other than influenza and HPV.  While 
participants often named ACOG’s recommendations as a key influence in immunization, 
the majority recognized that they were not aware of and may not be following all of the 
ACOG guidelines for immunizing.   
Prevalence of disease.  Another influence on the participants’ immunization 
practices was the prevalence of the diseases they most commonly treated.  For example, 
the diseases Participant E most commonly saw in his patients were the ones that most 
influenced his immunization practices.  “HPV and the flu in pregnancy are my main areas 
of concern because those are mostly my diagnosed [health problems]; my diseases that I 
take care of day to day.  That I’m seeing over and over and over.”  Participant S pointed 
out a similar experience. 
As far as an OB/GYN practice, that’s [HPV] the most prevalent thing that we see, 
we’re not dealing with a lot of hepatitis [A or B disease] – those people are going 
elsewhere.  Even the flu people – they are going to seek out other care when they 
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get the flu.  So, you know, the one that really impacts our practice is going to be 
the HPV vaccine.   
Thus, the diseases that the participants had the most experience treating were also the 
diseases for which they tended to offer vaccines.  
Experience with disease incidence and prevalence was also influential in 
participants’ immunization decisions.  As Participant N described,  
Prevalence, too, yeah, you know?  I haven’t taken care of one person who’s had 
hepatitis [B] since I’ve been here.  To say, does that mean that everyone is 
vaccinated against hepatitis [B] here, absolutely not, but the prevalence of 
hepatitis [B] here is so low that it’s like, if I’ve never seen a patient with hepatitis 
[B], then why would I be concerned?  Everyone could be vaccinated against 
hepatitis [B].  If hepatitis [B] was really prevalent here, then I would be all over 
the place making sure every one of my patients had hepatitis [B] vaccine. 
Participant N went on to use an example that further highlighted the relationship between 
prevalence and vaccination offerings,  
I guess it’s the prevalence of the things where I work…when we were in…, we 
took care of HIV [Human Immunodeficiency Virus] patients all the time.  And 
here, we haven’t seen one HIV patient.  So, if you don’t see it, you tend to forget 
about it.  If I worked somewhere like there was a Division I school, I’m sure I’d 
be current and up-to-date and giving everyone meningococcal vaccine, so I think 
if I don’t see the problem, I’m not really thinking about it.   
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Seeing patients with the disease seemed to influence the participants’ immunization 
practices and provided justification for both the vaccines they did and did not offer.    
Patient demand.  Another influence named by multiple participants was patient 
demand.  Many of the physicians reported experiencing an increase in patient demand for 
HPV vaccine once it became available, and named demand as a key influence in their 
decision to offer the vaccine.  As Participant N described,  
Even if it’s something that the patients don’t know should be important to them, if 
they’re not asking questions about it, and it’s not something I see a lot, then I 
don’t really push it.  So, I think patient demand really drives how much I talk 
about vaccines and which vaccines we offer in our office.  
In addition to HPV, a few participants reported patient demand for other vaccines, such 
as pneumococcal and shingles.  The practices that reported this demand were also the 
ones who offered these vaccines.   
Additional influences.  Other immunization practice influences named by the 
participants included: perceived importance of the vaccines, efficacy of the vaccines, and 
disease outbreaks.  Two participants reported seeing cases of rubella and pertussis in their 
community that influenced their decisions to offer those particular vaccines.   
In summary, a number of factors influenced the participants’ immunization 
practices, including ACOG’s recommendations, disease incidence and prevalence, 
particularly among patients, and patient demand.  These influences impacted the 
OB/GYNs in their decision to immunize.   
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Benefits 
Participants identified three main benefits to offering vaccines as a part of their 
medical practice: ensuring patient protection and community disease prevention, serving 
as a medical home for patients, and maintaining patient retention.  In addition to 
enhancing the participants’ vaccination experience, the benefits to immunizing also 
reinforced their decision to immunize.   
Patient protection & community disease prevention.  For the participants, 
prevention of disease and protecting their patients topped the list of benefits they 
associated with immunizing.  Many of them emphasized benefits for a specific 
population, such as pregnant women.  As Participant V described, “Well, especially in 
the pregnant population, it reduces risk for maternal, severe cases of disease like the flu 
for instance, and also neo-natal infections as well.”  Multiple physicians noted the 
benefits not just for pregnant women, but also for children in providing extra protection 
from harmful diseases. 
Several physicians specifically mentioned the benefits associated with offering 
the HPV vaccine.  They perceived benefits accrued not just to patient and community 
health, but also to the health care system in general.  Participant F described the benefits 
he associated with offering HPV vaccine: 
Really it’s going to eventually around the world save a lot of people’s lives, it’s 
also going to change the way we take care of patients for their pap smears.  The 
annual pap is not going to be as necessary, if you have HPV is negative, and you 
have a normal pap, the likelihood of cervical cancer is extremely remote, after 
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even three years, so you can kind of stretch these things out.  It’ll be a huge cost 
savings to the health care system in the long run.   
When describing the benefits of a specific vaccine, almost all of the participants focused 
on the benefits of HPV and influenza vaccines.  They rarely mentioned other vaccines 
during the discussion of benefits.   
Another immunization benefit the participants described related to the health of 
the community as a whole.  By vaccinating their populations, they were helping to reduce 
disease transmission and increasing community safety.  One participant described the 
benefit of offering vaccines in terms of how it affected not just the community health, but 
also her patients’ willingness to get their children vaccinated.  According to Participant 
G,  
If you vaccinate people appropriately, you know, for flu and for pertussis, they’re 
less likely to get sick, their children are less likely to get sick, and I mean, then 
they start thinking about their vaccines, and they’re more likely to get their kids 
vaccinated, too, if they get vaccinated and don’t have problems.   
Every OB/GYN interviewed named protecting their patients and preventing disease as a 
benefit.   
Medical home.  Some of the participants interviewed identified the fact that 
serving as a medical home for patients was a benefit to providing vaccines for them.  
They felt that their patients may not see any other health care provider and that offering 
vaccines ensured their patients’ protection and receipt of complete care.  Several of the 
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participants echoed the belief that, if they did not provide the vaccine, their patient would 
not get it elsewhere.   
Patient retention.  Some physicians saw patient retention as a beneficial outcome 
of offering vaccines.  Participant N described this benefit:  
If somebody’s going to ask for it and they don’t get it from us – then they’re 
going to go find another doctor that’s going to give it to them and that’s 
potentially a patient we lost to another doctor because we didn’t do something.   
Thus, providing vaccines was a service that a few of the participants identified as a 
benefit that would ensure their patients remained with their practice.   
None of the participants thought that vaccine provision would be a financial 
benefit for their office.  In fact, many claimed that administering vaccines resulted in lost 
revenue for their practices.  Nor did offering vaccines create new business for their 
medical practices.  However, several participants recognized the financial benefit to 
society and the health care system that vaccines could offer.  Participant D shared a 
perspective about the broader benefits of offering vaccines, “from the standpoint of a 
health system or our society, it’s certainly much cheaper to vaccinate than it is to treat 
disease.”   While some of the participants recognized the societal financial gains that 
vaccines provided, they indicated little financial benefit for their practice to immunize 
their patients. 
In summary, participants identified three primary benefits of offering vaccines to 
their patients: ensuring patient protection and community disease prevention; serving as a 
medical home for their patients; and maintaining patient retention. While they saw little 
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financial benefit to their practice to provide vaccines, other benefits reinforced their 
decision to offer them to their patients.   
Meaning of Immunizing 
Participants acknowledged that providing immunizations was meaningful to them 
in their roles as physicians.  The meaning that the participants assigned to the practice of 
immunizing reflected the benefits they identified.  They described the meaning of 
immunizing as offering complete care for their patients and ensuring patient retention.  
Providing complete care.  Most meaningful to participants was the opportunity to 
provide comprehensive care to patients.  They viewed immunizations as part of this 
comprehensive care.  As Participant S explained, “it means you’re trying to take the best 
care possible for your patient, especially if you’re responsible for a patient who’s not 
seeing any other doctors, so, just to offer as complete care as possible.”  Participant J 
took this idea one step further, and found meaning with the practice of immunizing not 
just for the impact it would have on her patients, but on the community as well.  
If you think about the oath you took as a physician, and the reason you became a 
physician is to, you want to be responsible for promoting good health and good 
health practices in your patients. I think you’re only helping to contribute to the 
well-being of your patient and to the community overall. 
Even Participant D, whose practice did not offer vaccines for the patients for whom he 
served as a specialist consultant, also described the meaning of offering immunizations in 
terms of providing complete care.  To many of the participants, providing vaccines meant 
they were providing quality and comprehensive care for their patients. 
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 To some of the participants, providing vaccines also meant that they would be 
impacting diseases that could harm their patients.  One participant described the meaning 
she found in being able to provide vaccines by relating it to her experiences working in 
Africa and seeing the effects the diseases can have on people.  Other participants 
expressed similar sentiments about the meaning of offering vaccines, but focused on the 
impact of specific vaccines.  For example, Participant K found particular meaning from 
offering the HPV vaccine, as it would impact a disease he saw frequently.    
For us, the biggest thing to offer many of these vaccines is that it gives us hope 
that we’re going to have a significant impact on one of the biggest problems that 
we deal with on a day-to-day basis.   
While some participants were able to identify the meaning that providing HPV 
had for their practice, they often also expressed uncertainty at why they did not derive a 
similar meaning from offering other vaccines.  Participants seemed to be able to derive 
meaning primarily from the vaccines that were most impacting their offices.  Vaccines 
other than HPV and influenza were not as meaningful to the participants.     
 Patient retention.  Other participants defined the meaning of offering vaccines in 
terms of ensuring patient retention.  Participant D explains:  
It probably also means that the patient is likely to stay with you for their whole 
life, if you do those sorts of things for them.  There’s some family physicians 
obviously and internal medicine physicians that will do pap smears and GYN 
care, so if they’re not getting what they need from you, they’ll go to an internal 
medicine doctor or family doctor who’ll say, I can do your pap smear as well,  
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you may no longer have that patient as your patient.  Patients would obviously go 
one place to get everything than go to two or three different.   
Participant V expressed a sense of personal satisfaction in being able to serve as a 
one-stop shop for his patients.  “I think it, there’s a sense of satisfaction, that I can offer 
everything my patients need. So, I’m a one-stop resource for my patient’s needs – testing, 
vaccines, medications, education, the whole nine yards.”  Several participants found the 
meaning in offering vaccines to be associated with ensuring that their patients stayed with 
their practice and could receive everything they needed. 
The participants’ derived meaning from offering vaccines in a number of ways.  
Some emphasized the comprehensiveness of care that offering vaccines symbolized; 
while others focused on the satisfaction associated with being a single point of care for 
their patients.  Regardless of how they defined the meaning of immunizations for their 
practice, every participant was able to identify some meaning that the act of offering 
immunizations provided for themselves and their medical practice.  This meaning, in 
turn, contributed to their decision to provide vaccines for their patients.   
Summary 
For participants in this study, their interpretation of the influences, benefits, and 
personal meaning of their vaccination practices impacted and reinforced their decision to 
immunize.  These factors helped the participants determine why the practice of 
immunizing was important to them, and influenced their decisions about which vaccines 
to offer and which patients to immunize.   
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Chapter Summary 
Four themes emerged from the data in this study that related to the participants’ 
experiences with immunizations.  These themes included the vaccination experience, role 
inconsistency, multiple barriers to providing immunizations, and the decision to 
immunize.  Chapter 4 explored these themes and described the participants’ defined role 
with immunizations, the assigned meaning to the practice of immunizing, and the 
influences that have impacted their immunization practices.   
 
 
CHAPTER 5: CONCLUSION/DISCUSSION/IMPLICATIONS 
In this chapter, the researcher will present a review of the findings associated with 
this qualitative study and conclusions drawn from the findings.  In addition, a discussion 
of the findings in the context of the research literature and theoretical framework of the 
study is included.  This chapter will conclude with an analysis of the implications for the 
field of health education and promotion and future research.   
Study Overview 
The purpose of this study was to explore how obstetrician-gynecologists 
perceived and defined their role in immunization and vaccine administration, including 
providing patient education about immunizations.  In addition, the researcher was 
interested in identifying the meaning that study participants derived from the practice of 
immunizing and the influences that have impacted their adolescent and adult 
immunization practices.  To achieve this purpose, the researcher conducted audio-
recorded, in-depth, open-ended interviews with 13 physicians who resided and practiced 
obstetrics and gynecology in North Carolina.  The researcher chose a qualitative 
methodology in an effort to better understand participants’ immunization-related beliefs, 
perspectives, and behaviors in the context of their OB/GYN medical practices.   
The theoretical framework of Health Belief Model (HBM) informed this study.  
The HBM suggests that a person’s perceptions are the basis for their likelihood of 
engaging in a recommended health action.  Changing their perceptions increases the 
likelihood that they will act on the health behavior recommendation.  The main 
components of the model include perceived severity, perceived susceptibility, perceived 
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benefits, perceived barriers, and cues to action (Hodges & Videto, 2005).  This theory 
provided a framework for understanding the immunization behaviors of the OB/GYNs.  
Health educators can also use this theory in developing successful and effective strategies 
and materials for outreach programs that will encourage OB/GYNs to expand their 
immunization service offerings.          
Health educators could use the data collected during the course of this study for 
determining strategies for adopting, expanding and improving adolescent and adult 
immunization services.  This study has also provided suggestions for future research.  In 
addition, the findings have implications for the field of health education and promotion.   
Discussion  
During the course of the interviews with study participants, the researcher was 
able to gain a better understanding of their attitudes and practices related to vaccine-
preventable disease and the perceptions and meanings they assigned to their role with 
immunizations.  A summary of the key findings from this research as well as a discussion 
of how those findings related to the research literature and theoretical framework is 
below.  The researcher used the components of the Health Belief Model, including 
perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and 
cues to action as the framework for discussing the key findings from this study.  
Vaccination Practice & Influences 
Vaccination practice.  Of the 13 participants interviewed for this study, one 
offered no vaccines; seven offered between one and three vaccines; and five offered four 
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or more vaccines.  The two most commonly offered vaccines were HPV and influenza.  
The vaccination practices of the participants varied by practice, vaccine, and patient.  
Other studies that have examined the vaccination offerings of OB/GYNs have 
been either specific to a particular vaccine or conducted several years before the number 
of vaccines available for adolescents and adults had expanded.  For example, Gottlieb et 
al. (2008) conducted a telephone survey of staff at medical practices in a four-county area 
in North Carolina with high cervical cancer rates to assess the availability of HPV 
vaccine.  The researchers found that 64% of the obstetrics-gynecology practices in the 
targeted geographical area offered the HPV vaccine (Gottlieb et al., 2008).  In the present 
study all but three of the participants offered the HPV vaccine.   
Clark et al. (2006) surveyed a national random sample of 212 obstetricians to 
assess their opinions about the Tdap vaccine just after the vaccine became available in an 
effort to determine the likelihood that obstetricians would recommend and administer the 
vaccine to their obstetric patients.   They found that 78% of respondents agreed or 
strongly agreed that they would likely recommend Tdap vaccine for women immediately 
after delivery if recommend by ACOG.  In addition, with regards to administration of the 
vaccine, study participants believed that adult primary care providers played a larger role 
in administering the Tdap vaccine than did OB/GYNs (Clark et al., 2006).  These 
findings about Tdap vaccine from the study by Clark et al. are somewhat supported by 
the findings from the present study, as this study revealed much discrepancy between the 
Tdap vaccination and recommendation practices of OB/GYNs.  The present study found 
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that five of the 13 participants’ offices had Tdap vaccine available, three would order it if 
necessary, and two would recommend it to their patients.   
One study investigated the vaccination practices of OB/GYNs with respect to all 
vaccines.  The Schrag et al. (2003) study sent a questionnaire to 413 ACOG Fellows who 
volunteered to participate regularly in surveys and to a random sample of 650 ACOG 
Fellows.  Of the approximately 600 ACOG members who responded to the questionnaire, 
the majority (64%) worked in medical practices that offered at least one vaccine to their 
patients.  The most common vaccines they offered were rubella and influenza vaccines, 
followed by hepatitis B vaccine and tetanus toxoid-diphtheria vaccine (Td) (Schrag et al., 
2003).   However, Schrag et al. conducted this study before the introduction of the HPV, 
Tdap, meningococcal, and shingles vaccines.  These findings differed from those 
associated with the present study, as all but one of the participants interviewed worked in 
practices that offered at least one vaccine to their patients.  The most commonly offered 
vaccines in the present study were influenza, HPV, rubella, and tetanus.     
Findings from the present study revealed participants’ variations in their 
vaccination offerings, especially in providing vaccines other than HPV and influenza.  
Each participant or practice offered a different combination of vaccines for their patients.  
In addition, participants differed on which vaccines they emphasized and to which 
patients they offered vaccines.  For example, some recommended and provided certain 
vaccines only for the women who considered them their primary care providers; others 
recommended and provided vaccines for their pregnant patients, or for their patients who 
are within the correct age range to receive a specific vaccine, like HPV.  
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The participants’ vaccination practices may have differed from those of other 
physicians within their practice, perhaps as a function of the clientele that a particular 
OB/GYN treated.  For example, participants with larger post-menopausal practices may 
have strongly promoted and encouraged pneumococcal vaccine, while their colleagues 
within the same practice, whose patient population may have reflected fewer older age 
patients, may not have thought to do so.  Likewise, OB/GYNs who served in a consultant 
specialist role or who were primarily involved in surgery might have been less likely to 
consider patients’ vaccine needs compared to other OB/GYNs whose practices were 
more focused on well-woman care and the provision of primary care.  So, although their 
medical practice may have decided to provide certain vaccines, unless all of the 
OB/GYNs affiliated with the practice recommended and promoted the vaccines among 
all eligible patients, missed immunization opportunities were possible.     
Findings from the present study revealed discrepancies between participants’ 
vaccination offerings and those recommended by ACOG, although ACOG offers clear 
recommendations about vaccines that OB/GYNs should provide for their patients 
(Appendix D).  This finding may point to a need for more education for OB/GYNs about 
available vaccines, patients eligible to receive them, and ACOG’s recommendations.   
Influences.  According to the research literature, OB/GYNs’ decisions to provide 
vaccines have been associated with two variables: working in a multi-specialty practice 
and self-identification as a primary care provider (Schrag et al., 2003).  However, this 
study identified three additional factors that influenced their decision to provide vaccines, 
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including awareness of and willingness to implement ACOG’s recommendations, the 
prevalence of disease, and patient demand.    
Most of the participants interviewed named ACOG’s recommendations as a key 
influence in their immunization practices.  This finding was consistent with other studies 
that have shown that ACOG’s favorable stance on an issue is a prerequisite to the 
adoption of the behavior by OB/GYNs (Schaffer et al., 2008).  However, despite its 
influence, several participants in this study acknowledged that they did not know about 
ACOG recommendations for some vaccines or were not following current ACOG’s 
recommendations for the vaccines.  ACOG has issued numerous Committee Opinions, 
encouraging its members to recommend and provide the rubella, influenza, HPV, and 
meningococcal vaccines to eligible patients (ACOG, 2002; ACOG, 2004; ACOG, 2005b; 
ACOG, 2006a).  In addition, ACOG has published recommendations that encourage 
OB/GYNs to assess and provide immunizations during preconception care and as a part 
of the periodic assessments for women of all ages (ACOG, 2005a; ACOG, 2006b).  
While ACOG’s recommendations are an important component of the participants’ 
decision to offer vaccines, they are not the only influence.  According to this study, a 
number of factors affected the participants’ decision to offer vaccines, including their 
perceived role with vaccines, their perceptions of themselves as primary care providers, 
perceived susceptibility of their patients and perceived risk of the disease, and perceived 
benefits and barriers to offering the vaccines.  Understanding how all of these factors 
related to and influenced participants’ decisions to offer vaccines had implications for the 
development of strategies that could change practice patterns so that more OB/GYNs 
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educate and provide vaccines for their patients, thereby protecting the women they serve 
against a greater variety of diseases.   
Perceived Role with Vaccines 
The participants in this study defined their role with immunizations either in terms 
of their primary care relationship with patients or by vaccine or population group.  For 
those who defined their role in terms of their primary care relationship with patients, their 
role with vaccines depended on whether or not patients saw them as primary care 
providers.   These participants felt that they had a greater role and responsibility to 
educate and vaccinate these women when they perceived themselves as serving as their 
patients’ primary care doctor.   
The participants who defined their role in immunization by vaccine primarily 
focused on the HPV and influenza vaccines.  They saw these vaccines as clearly fitting 
within their job responsibilities and saw other vaccines as less of relevant to their scope 
of practice.  The participants who defined their role by population group tended to focus 
on their most vulnerable patients.  They clearly saw an important role for themselves as 
immunizers for the HPV vaccine and, in the case of their obstetric patients, for the 
influenza vaccine; some also saw they played a role in immunizing women during 
preconception and post-partum periods.  Outside of the vaccines and populations 
mentioned, most of the participants saw themselves as playing little or no role with 
vaccinations.   
The differing opinions and inconsistency about their roles and responsibilities 
with vaccines found in this study is consistent with findings from a study conducted by 
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Gonik et al. (2000).   Gonik et al. (2000) assessed the immunization knowledge of 313 
ACOG members in Michigan using survey questionnaires. The researchers found that, 
while most OB/GYNs believed that the provision of vaccines should be within their 
scope of work, a discrepancy existed between their perceived role and vaccination 
practices.  The researchers concluded, “inadequacies in vaccine screening and 
administration are likely reflective of this overall perspective that such duties are outside 
the realm of routine practice” (Gonik et al., 2000, p. 84).  However, Gonik et al. (2000) 
completed their study prior to the introduction of the HPV vaccine.   
A review of the research literature revealed no additional studies that 
explored OB/GYNs’ overall role in vaccines, and only a few that have explored their 
role regarding specific vaccines.  For example, a study by Clark et al. (2006) found 
that the majority of OB/GYNs agreed that they had a role in promoting or providing 
education about the Tdap vaccine to individuals coming in close contact with infants, 
but not necessarily in administering the vaccine (Clark et al., 2006).  Using a mailed 
questionnaire, Zola et al. (1997) examined the attitudes and educational practices of 
264 OB/GYNs in San Francisco regarding the infant hepatitis B vaccination.  They 
found that the majority of the obstetricians surveyed believed in the provision of the 
hepatitis B vaccine at birth and that it was possible to educate all expectant mothers 
about it.  However, only 53% of the respondents in the study provided education 
about this vaccine to their pregnant patients (Zola et al., 1997).   
The ways in which participants defined their role with vaccines may be changing 
due to the introduction of the HPV vaccine.  This vaccine was strongly associated with 
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the prevention of cervical cancer, a major health issue for which participants assumed 
primary responsibility in their scope of practice.  In this study, the participants who 
defined their immunization role in terms of specific vaccines had primarily focused on 
the HPV vaccine.  Almost all of the physicians interviewed had it available in their office 
and provided it to their patients.   
Other studies that have investigated the OB/GYNs’ role with HPV vaccine have 
confirmed the strong support and sense of responsibility these specialists felt about the 
vaccine.  Even before the HPV vaccine became available, OB/GYNs welcomed the idea 
of this vaccine, with 92% claiming they were likely or very likely to use it once it became 
available (Schrag et al., 2003).  Since the introduction of the HPV vaccine in 2007, 
Gottlieb et al. (2008) reported that 64% of the obstetrics-gynecology practices in a four-
county area in North Carolina with high rates of cervical cancer offered the HPV vaccine.  
Their study concluded approximately a year after the introduction of the HPV vaccine, 
and suggested that, “obstetrician-gynecologists, who have not traditionally been vaccine 
providers but have been supportive of HPV vaccination efforts, have quickly put systems 
in place to make HPV vaccine available” (Gottlieb et al., 2008). The rapid response of 
participants in providing the vaccine suggested to Gottlieb et al. that OB/GYNs saw a 
role for themselves in promoting and providing HPV vaccine.  Findings from the present 
study provide support for this observation. 
In this study and others (Gonik et al., 2000; Clark et al., 2006; Zola et al., 1997), 
the participants clearly saw a role for themselves in educating patients about vaccines.  
Yet, while they saw a role for themselves as educators, they offered little educational 
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materials outside of information about HPV and influenza vaccines.  They also did not 
utilize all the opportunities they had available to discuss immunizations with patients and 
did not frequently recommend vaccines to patients other than HPV and influenza.   
While they may have seen themselves in the role of educator, the participants in 
this study reported concerns about issues that presented barriers in educating their 
patients about vaccines.  They recognized that once they raised the issue of vaccines with 
patients, their patients would have potentially time-consuming questions and concerns 
related to the disease the vaccine prevented as well as the side effects associated with the 
vaccine.  In addition, not all participants felt well-informed about vaccine-related issues, 
particularly regarding side effects, and this decreased their comfort in providing patient 
education.   
Findings from this study suggested that participants viewed themselves as having 
an important role in vaccination but a role that was less clear in terms of providing 
vaccine-related education and administration, particularly since their views changed 
depending on the vaccine and patient age group in question.  Improving the 
inconsistencies in how they defined their role with immunizations could necessitate on-
going opportunities to clarify their role as primary care providers.    
Perceived Role with Primary Care 
Almost all of the participants interviewed worked in general OB/GYN practices 
that provided routine obstetric and gynecology services as well as primary care services.  
Of those providing primary care services, the participants estimated that between 20% 
and 80% of their patients considered them their primary care provider.  They described 
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the women who considered them primary care providers as relatively healthy, 
reproductively active women between the ages of 18 and 50 years.   
The population of reproductive age women for whom participants in this study 
were providing primary care services was consistent with that described in other studies 
(Gonik et al., 2000).  Schaffer et al. (2008) assessed the adolescent-immunization 
delivery among candidates in seven non-traditional vaccination settings including 
OB/GYN offices.  They noted that, “although few adolescents under 15 years of age see 
obstetrician-gynecologists, one third of all medical visits for women aged 17 to 21 years 
of age are to obstetrician-gynecologists” (Schaffer et al., 2008, p. S39).  Leader and 
Perales (1995) examined three national databases to determine differences in care 
provided to women during medical examinations by three medical specialties.  They 
found that “gynecologists are also the exclusive providers of primary care to substantial 
segments of women in the United States, especially women in their prime reproductive 
years” (Leader & Perales, 1995, p. 395).   
OB/GYNs are an important provider of primary and preventive care for women.  
However, the participants in this study reported an ongoing debate within their specialty 
about the types and amount of primary care they should be offering.  Some felt that 
because their patients considered them primary care doctors, they should be fulfilling the 
duties associated with that role, including providing vaccinations.  Others disagreed with 
the stance that they were primary care providers.  They did not feel as knowledgeable 
about some of the primary care responsibilities, including vaccines, and preferred for 
other, better-informed physicians to offer those services.   
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The research literature notes this reported division among the OB/GYNs about 
their primary care responsibilities.  Lentz, Ayala, & Eckert (2006) used a retrospective 
cohort design to compare demographics and prevalence of diagnosis codes for patients 
seen by OB/GYNs.  They reported that almost half of all OB/GYNs considered 
themselves to be primary care providers (Lentz et al., 2006).  While the percentage of 
OB/GYNs who considered themselves to be primary care providers varied by study 
(Stovall et al., 2007; Leader & Perales, 1995; Gonik et al, 2000), they agreed that women 
of reproductive age were most likely to be seeking primary care services from their 
OB/GYNs.  
Studies that have explored the OB/GYNs’ role with primary care in relation to 
vaccines have found that those, “who identified themselves as primary care providers had 
an increased likelihood of vaccine provision” (Schrag et al., 2003, p. 708).   The present 
study reflected this relationship between the primary care role and vaccine offerings and 
the division among the OB/GYNs about their primary care responsibilities.  Almost half 
of the participants saw vaccines fitting within their routine screening, prevention, and 
primary care scope of duties.  However, they disagreed as to which vaccines specifically 
fit within this scope.  Other participants felt that vaccines other than HPV and influenza 
vaccine were outside of their responsibilities and did not fit within their responsibilities.   
In an attempt to help clarify the role of OB/GYNs with primary care,  
ACOG has identified three levels of gynecologic care: traditional specialty care, 
primary preventive care, and extended primary care.  OB/GYNs who provided 
primary preventative care emphasized health maintenance for women and provide 
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health screening; those physicians who provided extended primary care not only 
offered primary prevention but also treated medical conditions beyond the 
reproductive system. (Boyle, 2006, p. 1666)   
In addition, at the time of the present study OB/GYN residents were required to have 
training in primary care and ACOG has encouraged OB/GYNs to not only provide 
primary care services during preventive examinations, but also to manage minor chronic 
medical problems (Boyle, 2006).   
The diversity of participants’ viewpoints about their roles as primary care 
providers documented in the present study reflected the continued struggle with the role 
among OB/GYNs as a whole.  Boyle perhaps described the debate best:  “Although the 
specialty as a whole cannot decide how they feel about primary care, the reality is that 
they are well positioned to deliver it” (Boyle, 2006, p. 1666).  The ongoing disagreement 
about their role in primary care and the specific vaccines that fit within their scope of 
practice will continue to impact the immunization practices of OB/GYNs in a significant 
way.  If vaccination advocates can encourage OB/GYNs to broaden their scope of work 
to include more vaccines as part of their primary care responsibilities, then more 
OB/GYNs might be willing to offer vaccines.   
Perceived Severity 
According to the HBM, perceived severity refers to “one’s own assessment of the 
seriousness of a health problem” (Hodges & Videto, 2005, p. 183).  The participants in 
this study provided vaccines for the diseases they most commonly treated in their offices, 
such as HPV and influenza, both of which could have devastating outcomes in the 
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absence of immunization.  Participants named prevalence and severity of the disease as 
some of the key influences in their decision to provide the vaccine.  The research 
literature supports this finding.  Gonik et al. (2000) noted that, “survey respondents who 
were more knowledgeable about vaccine-preventable diseases were more likely to 
incorporate screening and vaccine administration in their practices” (Gonik et al, 2000, p. 
84).  However, no other studies were identified that discussed the prevalence of the 
disease as an influential factor in OB/GYNs’ decision to provide vaccines.      
First-hand knowledge about the severity of the disease seemed to influence the 
participants’ decision to provide HPV and influenza vaccine.  However, beyond these 
vaccines, few participants provided or seemed interested in providing vaccines to protect 
their patients against other potentially serious diseases such as meningococcal, pertussis, 
hepatitis A, hepatitis B, pneumococcal or shingles.  This may be in part because they 
rarely saw patients impacted by these diseases and might never have treated anyone 
infected with one of them.  Clearly communicating the severity of all of the vaccine-
preventable diseases and the risks that their patients are taking by remaining 
unimmunized may contribute to a pro-vaccination stance on the part of providers.  
OB/GYNs might reconsider their immunization practices and offer a greater number of 
the vaccines recommended for adolescents and adults.   
Perceived Susceptibility 
The HBM defines perceived susceptibility as “one’s own assessment of the level 
of risk of experiencing a health problem” (Hodges & Videto, 2005, p. 183).  The 
participants in this study primarily offered vaccines for the patients they considered the 
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most vulnerable to the disease in question.  For most of the participants, this included 
providing influenza vaccine for their pregnant and elderly patients and providing HPV 
vaccine for women under the age of 26 years who were most susceptible to the disease.  
The participants typically offered the other vaccines to women who were at greatest 
perceived risk for the disease or in spreading the disease to vulnerable populations.  For 
example, participants in a few medical practices recommended and offered the Tdap 
vaccine to their preconception and postpartum women to help prevent the transmission of 
pertussis from mother to child.  Other studies that have examined the vaccination 
practices of OB/GYNs have not assessed the patients to whom they were providing 
vaccines.   
Participants in this study did little to assess the extent to which their patients were 
susceptible to the various immunization-preventable diseases.  They tended to assume 
that the women they saw were up-to-date with the necessary vaccines or could receive the 
vaccine from other providers.  The results of studies by Rand et al. (2007) and Malone, 
Gonick and Tomlinson (2002) challenge this assumption.  Rand et al. (2007), for 
example, found that women over the age of 18 visited OB/GYNs more than any other 
type of physician.  In addition, they observed that adolescent and adult vaccination rates 
are dangerously low.  Malone et al. (2002) specifically examined vaccine awareness of 
482 patients at different OB/GYN settings through the use of a questionnaire. Their study 
revealed that most patients visiting an OB/GYN practice had inadequate immunity to 
common vaccine-preventable diseases.  In addition, more than one-third of participants in 
that study could not identify a site to meet their current vaccine administration needs 
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(Malone et al., 2002).  The study also found that the “overwhelming majority of patients 
surveyed expressed a strong desire to use their obstetrician/gynecologist office for such 
services, if the services were made available” (Malone et al., 2002, p. 197).  The 
assumption that patients are up-to-date in their immunizations or able to receive their 
vaccines elsewhere may not be accurate.  Such an assumption may leave a number of 
women of reproductive age unimmunized and unprotected.   
In addition to the perception that many of their patients were up-to-date or could 
receive the vaccine from another provider, the participants in this study did not 
necessarily remember to provide the vaccine to all eligible patients.  For example, some 
practitioners may link Tdap vaccine with wound treatment and not realize the 
recommendation includes all adults between 18 and 64 years of age.  In addition, 
recommendations for Tdap include all post-partum women.  Similarly, with 
meningococcal, they may not have realized that all women between age 11 and 18 years 
are eligible to receive the vaccine.  Simply encouraging the OB/GYNs to think beyond 
the most vulnerable patients and to consider all of their patients recommended to receive 
the various vaccines may help increase their opinions about the susceptibility of their 
patients to vaccine-preventable diseases.   
Perceived Benefits 
The Health Belief Model’s construct of perceived benefits refers to an 
individual’s assessment of the benefits of participating in a recommended health-related 
behavior (Hodges & Videto, 2005).  The participants in this study were able to identify 
three main benefits to offering vaccines: ensuring patient protection and community 
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disease prevention; serving as a medical home for their patients; and maintaining patient 
retention.  The participants focused primarily on the benefits relating to immunization 
with HPV and flu vaccines.   
Physicians who participated in the study named protecting their patients and 
preventing disease as a benefit to vaccinating.  Many of the participants also recognized 
that they were serving as a medical home for many of their patients who did not see other 
physicians.  Because of this belief, several felt that offering vaccines ensured their 
patients’ protection and receipt of complete care, and they saw this as another major 
benefit.  Other physicians saw patient retention as a benefit to offering vaccines.  
Providing this service was a way to ensure that their patients remained with their practice.  
None of the participants interviewed saw a financial benefit to providing vaccines.    
These findings are not comparable to other similar studies in the research 
literature, because previous studies tended to focus exclusively on immunization barriers. 
However, the medical benefits of vaccines are well known.  They are effective at 
preventing disease among individuals and in ensuring the health of the community.  
Vaccines also benefit the health care system in that they are a cost-effective way to 
prevent disease.   
According to an extensive cost-benefit analysis by the CDC, every dollar spent on 
immunization saves $6.30 in direct medical costs, with an aggregate savings of 
$10.5 billion.  When including indirect costs to society -- a measurement of losses 
due to missed work, death and disability as well as direct medical costs -- the 
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CDC notes that every dollar spent on immunization saves $18.40, producing 
societal aggregate savings of $42 billion. (Every Child by Two, 2009)    
While the providers in this study did not see an immediate financial benefit to offering 
vaccines, their involvement in immunization contributed to reduced health care costs 
associated with disease management.    
Interestingly, in this study the benefits of offering vaccines that participants 
identified were similar to how they derived meaning associated with immunizations. 
They described finding meaning in offering complete care for their patients and ensuring 
patient retention as a consequence of offering immunizations.  To some participants, 
offering vaccines meant that they were providing complete, comprehensive care to their 
patients and were affecting the diseases, such as HPV and influenza, which were most 
likely to impact their patients’ health.  Others found that offering immunizations meant 
that their patients were likely to stay with their practice and could receive everything they 
needed.  To the participants in this study, the benefits of providing vaccines were similar 
to the meaning that they derived from the act of offering immunizations for their patients.  
Perceived Barriers 
The HBM construct of perceived barriers refers to an individual’s assessment of 
the obstacles to participating in a recommended health-related behavior (Hodges & 
Videto, 2005).  The participants in this study were able to identify four main barriers to 
vaccinating: cost, logistics, patient knowledge, and provider knowledge.  The barriers 
identified in this study were similar to findings in quantitative studies that have described 
the vaccination practices among OB/GYNs.  Previous studies have identified financial 
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barriers, supply and demand issues, patients’ educational background, and the OB/GYNs’ 
attitude and education about vaccines as barriers to immunization (Schrag et al., 2003; 
Gonik et al, 2000; Leaphart, Seigler, Arnold & Bivins, 2003).  Gonik et al. (2000) also 
found that the OB/GYNs’ belief that ‘it is not part of my usual patient care activities’ was 
a barrier to administering vaccines, as was uncertainty regarding current vaccine 
recommendations, lack of comfort with administration, and the perceived unwillingness 
of patients to accept the vaccine.  While the four main barriers found in the present study 
were similar to previous findings, the present study revealed additional barriers relating 
to provider knowledge not yet identified in the research literature.  A discussion of how 
the barriers identified in this study relate to previous studies follows.   
Cost.  Cost as a barrier, including both the cost to store the vaccine and the 
reimbursement rates, was mentioned numerous times by participants, not just in this 
study, but in several others.  However, cost does not have to be a barrier for OB/GYNs, 
especially for their younger patients.  Informing these doctors about the existence of the 
state’s immunization program, which enables physicians to provide the required and 
recommended vaccines to their eligible patients, free of charge, may be one way to 
reduce cost as a burden to the practice for offering immunizations to their patients under 
the age of 18.  Also, in most cases, OB/GYN practices and the various third-party payers 
contractually establish the reimbursement rates between themselves.  To reduce this as a 
barrier, the OB/GYNs may need to consider renegotiating their rates with these 
companies.      
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OB/GYNs in private practice must consider the cost and benefit ratio to providing 
any service, and unless the reimbursement for vaccines improves, there will be little 
incentive for the OB/GYNs to offer more vaccines.  While the practice of writing 
prescriptions may help the providers save money on storing the vaccines, this practice is 
not ideal, for it puts the viability of the vaccine into question.  Having a patient 
responsible for maintaining the correct temperature and handling the vaccine 
appropriately until they can return to the provider’s office to receive it puts the 
effectiveness of the vaccine in jeopardy.   
Patient knowledge.  Patient fear, misinformation, or lack of education about 
vaccines is a barrier to all vaccine providers, not just OB/GYNs.  Fortunately, 
overcoming patient misconceptions about vaccines can be as simple as providing 
education about the importance, safety, and efficacy of vaccination (Leaphart et al, 2003).  
Addressing patient concerns about vaccine safety seems to be a large barrier facing the 
OB/GYNs and one that may require additional training for the physicians to appropriately 
address.  For example, this study found that some OB/GYNs were answering questions 
from their pregnant patients about vaccines and its relationship to autism.  However, not 
all of the information that the study participants were relaying to their patients was 
accurate, and may point to the need for additional education about this issue.   
Increasing patient knowledge about their need for vaccines was another matter.  
In this study, flu and HPV vaccines were the vaccines most often requested by the 
participants’ patients, but the OB/GYNs reported that these requests were very 
infrequent.  The participants typically had to broach the subject of immunizations with 
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their patients.  Many studies have shown that the majority of adults are unaware of their 
need for vaccine, but such studies also found that one of the strongest predictors of 
immunization is a physician’s recommendation to receive the vaccine (Ashby-Hughes & 
Nickerson, 1999). 
One participant in this study related a parent’s concern that receiving HPV 
vaccine might encourage sexual activity in their children.  Other studies that have 
explored provision of the HPV vaccine have identified this issue as a barrier (Keating et 
al., 2008).  However, a study by Brewer, Cuite, Herrington and Weinstein (2007), which 
specifically investigated whether receiving a vaccine can cause people to engage in risky 
behaviors by interviewing 705 adults over the telephone, found support for the belief that 
vaccines could reduce protective behaviors, but the evidence was not strong enough to 
support the belief that vaccination with HPV vaccine would cause or promote sexual 
activity (Brewer et al., 2007).   
Provider knowledge.   One component of this barrier related to participants’ 
remembering to incorporate vaccines into their daily routine.  Finding ways for 
OB/GYNs to remind themselves to talk about vaccines with their patients as part of their 
routine physical may be all that is necessary to overcome this barrier.  This could include 
the use of standing orders or examination checklists by population group by the 
physicians.  In addition, encouraging OB/GYNs to use all of their visits, and any 
additional points of contact with their patients, to discuss appropriate immunizations can 
result in fewer missed opportunities for vaccination.  Also, ensuring that the OB/GYNs 
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know which vaccines to discuss at these opportunities may help improve the vaccination 
practices and uptake at their offices.   
Another way to overcome this barrier would be to make it more part of the culture 
of the OB/GYN’s office.  For example, Participant H’s medical practice was not in the 
habit of offering many vaccines, and he felt that if his partners were more willing to 
discuss and offer a broader array of vaccines, then his own mindset about vaccines might 
change.  Overcoming the barrier of incorporating vaccines into the daily habits of the 
OB/GYNs and the practices is possible, but it requires commitment and dedication on the 
part of the physicians and their office staff.   
While barriers to immunizing certainly exist, the participants’ perceptions about 
the number and the difficulty of these barriers may be greater than warranted.  In this 
study, it appeared that the participants who identified the most barriers to immunizing 
were also the ones who offered the fewest number of vaccines.  Other studies have also 
noted this finding.  For example, Keating et al. (2008), conducted telephone interviews 
with medical practices in North Carolina to assess potential concerns about HPV vaccine 
provision and found that, “practices not providing the HPV vaccine consistently had 
more concerns than did HPV vaccine providers” (Keating et al., 2008, S65).  Providing 
vaccines may not be as difficult as the OB/GYNs’ perceive, and their reluctance to do so 
may be because of their resistance to change more so than the actual barriers that exist.  
Pediatricians and family practitioners have been immunizing children for decades, 
and have had experience overcoming barriers relating to assessing patients immunization 
status, dealing with reimbursement and cost issues, managing the storage and handling 
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logistics, and overcoming patient misperceptions about vaccines.  OB/GYNs have 
traditionally had limited exposure to the practice of immunizing and may be unfamiliar 
with strategies useful in overcoming some of the barriers associated with this service.  
The OB/GYNs may be able to learn from pediatricians and family practitioners about 
how best to manage the vaccines and immunize the patients in their practices.  Finding 
ways to reduce the OB/GYNs’ perceptions of these barriers and to increase their sense of 
self-efficacy with the administration of vaccines may help enhance the immunization 
offerings in these practices.   
Cue to Action 
In the HBM, cues to action refer to reminders that may help start or encourage the 
desired behavior (Hodges & Videto, 2005).  Encouraging OB/GYNs to incorporate 
vaccines more fully into their practice may not be too difficult if health educators utilize 
the correct cues to action.  In this study, at the conclusion of the interview, the 
participants would ask the researcher about ways in which they could improve their 
immunization services or would suggest a need existed to consider providing one or more 
of the vaccines for their patients.  Most of the participants expressed a willingness to 
vaccinate; however, they were unsure about how to overcome some of the barriers 
associated with immunizing.   
The researcher asked participants in this study who were uncomfortable or not 
interested in having a larger role with immunizations about what strategies would 
encourage them to provide more vaccines.  Their responses often involved finding ways 
to remind them to incorporate the process of immunizing into their daily practice, either 
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through offering financial incentives, incorporating systems that would alert them about 
the recommended vaccines, or providing additional education about primary care 
responsibilities during residency.   
On the patient side, providing additional education about the immunizations 
offered at their practice may help to increase patient demand for the vaccines.  As the 
study by Malone et al. (2002) demonstrated, many OB/GYN patients were willing to use 
their OB/GYN for vaccination services, if vaccines were available.  All of the 
participants who offered vaccines in the present study reported that they had some type of 
education material about vaccines, but their educational offerings were limited and 
mainly focused on the HPV vaccine.  Increasing the amount and availability of quality 
patient education materials may help educate women about the immunizations they need 
and may increase the patients’ demand for the vaccines.  
Simply finding ways that the OB/GYNs can better incorporate immunizations as 
part of the standard routine of case during patient visits and increasing the patients’ 
knowledge about the existence of and availability of such vaccines may serve as needed 
cues to action that can facilitate behavior change for both the OB/GYN and the patient.  
Strengths & Limitations 
This study has both strengths and limitations.  Qualitative data provided detailed 
information about the OB/GYNs’ perceptions and experiences with immunizations.  The 
defined meaning, perceived role, influences, and beliefs of the OB/GYNs affect their 
immunization practices and provide suggestions for areas in need of additional study.   
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The qualitative design for this study included a purposive sample of OB/GYNs.  
Due to purposive sampling, findings associated with this study cannot be generalizable to 
all OB/GYNs. However, the findings from this study may be transferrable to similar 
individuals under similar circumstances.   
One limitation of this study was that the researcher was unable to interview any 
general practice OB/GYNs who did not offer any vaccines.  Their lack of representation 
may affect the findings.  In addition, because the researcher collected data through the 
use of face-to-face interviews, the potential for response bias was greater.  This bias 
occurs when the participant seeks to please the person conducting the interview (Crosby, 
DiClemente, & Salazar, 2006).  The researcher’s knowledge about vaccines and presence 
may have had an impact on the participants, and also on the research findings.  Although 
the researcher attempted to avoid this bias by keeping her body language and comments 
neutral, this type of bias may still have occurred.  The researcher also assumed that the 
participants answered honestly and truthfully during the course of the interview.  She also 
assumed that participants answered according to what they felt or believed about the 
topic, not what they perceived to be socially acceptable or the ‘right’ answer.  These 
assumptions may be a limitation of the study.   
Another potential limitation occurred due to a discrepancy in how the researcher 
and the participants defined the term “offered.” Some of the physicians would state they 
offered a particular vaccine, but upon further questioning, revealed that they did not have 
the vaccine physically in their practice.  Some would state they offered it, but meant 
either that they would recommend it, or that they would be willing to order it or write a 
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prescription for it and have the patient come back to the practice to receive it.  The 
researcher made attempts to clarify the participant’s meaning during the course of the 
interview, but the report of immunization practices may be inaccurate.  Lastly, the 
findings in this study could be subject to other interpretations.   
Implications for Health Education & Promotion 
Findings from this study have implications for the field of health education and 
promotion, as they may suggest strategies for how health educators can best develop 
effective outreach programs that will encourage the expansion of vaccination services 
and enable OB/GYNs to more completely vaccinate the patients they serve.  These 
strategies could potentially include implementing policy changes, developing educational 
programs, and utilizing the Health Belief Model.      
One way health educators can encourage the expansion of vaccination services of 
the OB/GYNs is by implementing policy strategies that impact their practices.  For 
example, health educators can strive to communicate state requirements for screening, 
education, or vaccination of certain populations of women.  An example of this might be 
a state guideline that requires all post-partum women to receive a dose of Tdap vaccine, if 
it has been more than five years since their last dose of tetanus-containing vaccine.  
Another example could be a state policy or guideline that requires all pregnant women to 
receive information about the vaccines that they and their child will need.  Health 
educators could work with their local and state legislative representatives to introduce 
and enact policy changes.   
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The policy strategies can impact areas other than state requirements.  Health 
educators can also partner with insurance companies, including Medicare and Medicaid, 
to mandate certain screenings or immunizations for certain populations.  For example, 
health educators could collaborate with Blue Cross Blue Shield to create a mandate that 
all women over the age of 60 receive education about and have the opportunity to obtain 
the shingles, pneumococcal and influenza vaccines.  Finding ways to enact policies, both 
in state government and with those paying for vaccines, might be one way health 
educators can impact the vaccination practices of OB/GYNs.   
This study also has implications for the field of health education and promotion, 
as one considers the educational needs of the OB/GYNs.  Health educators can 
implement educational outreach strategies that improve the providers’ knowledge about 
many different aspects of immunizations, including who is eligible to receive the 
vaccines, proper storage and handling procedures (including the practice of prescription 
writing), and common side-effects.   
In addition, health educators can implement education strategies that address 
OB/GYNs’ knowledge about common vaccine concerns.  For example, this study found 
that some participants were answering questions from their pregnant patients about 
vaccines and its relationship to autism, but were doing so with inaccurate or outdated 
information according to the Institute of Medicine (IOM, 2004).  The evidence 
overwhelming demonstrates that there is no link between autism and vaccines, and the 
studies that had shown association between the two variables has been discredited 
(National Network for Immunization Information, 2009).   OB/GYNs who are answering 
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questions about associations between autism and vaccines should be well versed in this 
issue and able to ease their patients’ fears.  If OB/GYNs address this fear, it might be 
beneficial for health educators to assure the availability of current information and ensure 
that OB/GYNs have readily available access to the latest research on this topic. An 
educational campaign should include components that teach OB/GYNs how to 
effectively address this concern.  In addition, an educational campaign could include a 
variety of other immunization-related topics so that OB/GYNs are well-informed about 
all components of vaccinating.  
One way health educators can address the educational needs of OB/GYNs is by 
providing Continuing Medical Education (CME) credits to these physicians and their 
staffs for attending lectures or presentations about adolescent and adult vaccinations or 
about how to successfully implement or expand the immunization services in their 
practice.  These lectures or presentations could be located at any number of places, 
including Grand Round events at hospitals; within the physician’s office; or at regional 
Area Health Education Centers (AHEC).  Another way health educators could enhance 
the immunization education of OB/GYNs is by holding regional or statewide 
immunization conferences, meetings, and training programs.   
Health educators could also develop online education seminars about adolescent 
and adult vaccinations that the OB/GYNs could receive CME credit for completing.  
Other ways to reach these physicians could include partnering with organizations such as 
the North Carolina OB/GYN Society, the North Carolina Medical Society, or the local 
ACOG districts.  Health educators could also work with residency programs at local 
123  
 
medical colleges to develop curriculum for the OB/GYN residents about vaccinations.  
These partnerships could alert health educators to opportunities to reach their members 
and could serve as useful vessels for disseminating important vaccination information 
and CME opportunities. By improving OB/GYNs’ education and knowledge about 
vaccines, health educators may be able to influence OB/GYNs’ vaccination offerings so 
that more of their patients are educated about and offered vaccines. 
Before health educators implement strategies to enhance OB/GYNs’ knowledge 
about immunizations, they should collaborate with the physicians during the development 
of the educational outreach components.  Incorporating the OB/GYNs’ feedback about 
the type of information offered, the format in which it is presented, and the best methods 
to reach them with the information will ensure that the outreach is effective and 
successful in accomplishing its goals.  Without the vital feedback of the OB/GYNs, 
health educators may struggle in the implementation of educational outreach strategies to 
this group.   
Utilizing the Health Belief Model as a framework for outreach strategies is a third 
potential way that health educators can facilitate change in OB/GYNs’ vaccination 
practices.  This model may also provide insights into the best types of messages to 
include in educational materials that will have the greatest affect on the vaccination 
behaviors of the OB/GYNs.  For example, health educators can focus on messages that 
strive to improve the perceptions of OB/GYNs about their non-pregnant patients’ 
susceptibility with certain vaccine-preventable diseases.  Helping OB/GYNs understand 
the actual number of their patients that are susceptible to meningococcal, HPV, flu, 
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pertussis, hepatitis A, hepatitis B, pneumococcal, and shingles will allow them to assign 
the appropriate level of risk these patients face by being unimmunized and may cause 
them to provide more vaccines.  Additionally, improving OB/GYNs’ perceived severity 
of these diseases by clearly communicating the consequences of not being immunized 
can improve their perceptions of this threat.   
Reducing the perception of barriers may be a particularly important step that 
health educators can take to change immunization behaviors with this group.  Health 
educators can do this in a number of ways.  For example, to reduce cost as a barrier, 
health educators can develop messages that educate OB/GYNs about the existence of the 
State Immunization Program, which provides free vaccine to providers for use with all 
children under the age of 18 years.  Health educators can also encourage OB/GYNs to 
renegotiate their third-party contracts to get better reimbursement rates for immunization 
administration.  To reduce OB/GYNs’ own knowledge about immunizations as a barrier, 
health educators can help these physicians understand what ACOG’s recommendations 
are for vaccines, which patient populations are eligible to receive the vaccines, what 
opportunities they have to discuss immunizations, and what they can do to help 
remember to incorporate vaccines into their daily routines (i.e., cues to action).  Health 
educators can also strive to clarify all of the benefits of providing vaccines.   
The findings from this qualitative study have implications for the field of health 
education and promotion.  Health educators can use the data from this study to develop 
effective outreach programs that will encourage the expansion of vaccination services 
and enable OB/GYNs to vaccinate more completely the patients they serve.  They can 
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use strategies such as implementing policy changes, developing educational programs, 
and utilizing the Health Belief Model to bring about change in OB/GYNs’ immunization 
practices.  Using these strategies may vastly enhance OB/GYNs’ practice of 
immunization. 
Implications for Future Research 
The findings from this study suggest several areas for future research.  This study 
did not include general OB/GYN practices that did not offer any vaccines.  Their 
opinions and perspectives about vaccines may be far different from the OB/GYNs 
interviewed in this study, and additional research is necessary to capture their perceptions 
about vaccines.   
To date, the majority of studies that have examined OB/GYN vaccination 
practices or their role with vaccines were prior to the introduction of the meningococcal, 
HPV, Tdap, and shingles vaccines.  A survey that assesses the immunization practices 
and opinions of OB/GYNs in light of these new vaccine offerings may shed more light 
onto the changing immunization practices and beliefs of these physicians.  In addition, 
research that examines the OB/GYNs’ knowledge about ACOG’s recommendations for 
immunizations may provide interesting information.   
Studies that examined OB/GYNs’ specific vaccination practices might also prove 
useful.  For example, determining the frequency in which the OB/GYNs were taking 
opportunities to discuss vaccines, to educate patients about vaccines, and to assess their 
patient’s immunization status might provide helpful data about the actual immunization 
practices of these providers.  Another potential study that might provide beneficial 
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information is one that assessed the cost to the practice to provide the vaccines and the 
reimbursement rates available.   
Qualitative studies that examine OB/GYNs’ perspectives and opinions about any 
health related issue are largely lacking from the research literature.  The researcher was 
only able to identify one other qualitative study that examined the OB/GYNs’ 
perspectives about another health topic.  Having this rich, thick descriptive data is 
important to supplement the quantitative research already completed with these 
physicians. 
Conclusion 
OB/GYNs are certainly in a unique position to enhance the health of their patients 
by offering vaccinations.  While the OB/GYNs in this study were willing to educate their 
patients about vaccines, their view of their role with vaccines, and with primary care, was 
inconsistent and varied by provider.  Efforts to expand the vaccine services offered in 
these settings should utilize the Health Belief Model framework and focus on increasing 
the OB/GYNs’ perceptions about the severity of the diseases; the susceptibility of their 
patients; and the benefits to vaccinating.  In addition, reducing the barriers to vaccinating 
and enhancing their reminders to act will potentially have lasting effects on the 
OB/GYNs’ practice of immunizing.   
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APPENDIX A: ADVERTISING FLYER 
 
 
Dear OB/GYN: 
 
I need your help!  My name is Amanda Dayton, and I am a graduate student at East 
Carolina University.  I am working on my master’s thesis, which is about OB/GYNs’ 
perceptions of their role in vaccinations.   
 
I am looking for OB/GYNs to volunteer to be interviewed about their vaccination 
practices and beliefs.  You DO NOT have to administer or offer vaccine in order to 
participate.  In fact, I’d like to speak to OB/GYNs who don’t provide ANY vaccine, as 
well as those that offer multiple vaccines to their patients.   
 
If you are interested and willing to be interviewed, please contact me at: (919) 523-4440 
or by email at amanda.dayton@yahoo.com.  The interview should last no more than one 
hour and can be scheduled to occur at a time and location convenient to you.  I am more 
than willing to work around your schedule, and can even come to the hospital while you 
are on-call.  I can also do the interview over the telephone.      
 
Thank you so much for your consideration.  I hope to hear from you soon!       
 
Sincerely,  
 
Amanda Dayton 
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APPENDIX C: INTERVIEW GUIDE 
 
1. How are you currently using vaccines in your practice?  
a. What vaccines offered? 
b. Age groups/populations immunized? 
c. Why particular vaccines offered? 
d. Why some not offered? (meningococcal, HPV, Tdap, flu, shingles, etc.) 
e. What ones considered? 
f. How/when assess patient’s immunization status? 
 
2. What do you see as the benefits to offering vaccines? 
a. How often patients request? 
b. Which ones most frequently requested? 
 
3. What are the barriers or obstacles in offering vaccines? 
a. Concerns about offering? 
b. Patient questions about vaccine safety? 
c. Own questions about safety? 
d. Willingness of various populations (such as Latinos or African 
Americans) to receive vaccines? 
e. How do you stay current with vaccine recommendations? 
f. How do you handle the logistics of administration? Storage and handling? 
Reimbursement?  
 
4. What do you see as the OB/GYNs role in vaccination? 
a. Education / Counseling?   
b. Administration? 
 
5. Where do you think immunization fits within the realm of routine OB/GYN care? 
a. Willingness to offer vaccines outside of practice’s scope of work? 
b. Meaning for OB/GYNs to be able to offer?   
c. Meaning for you to offer? 
 
6. What factors have influenced your immunization practices? 
a. Impact of ACOG’s recommendations on decision to offer? 
b. Who makes the decision to provide/not provide vaccines? 
c. Process to expand or limit vaccines offered? 
 
7. Tell me about the immunization educational materials you provide to patients 
interested in particular vaccines?  
a. What is missing?   
b. What ed materials needed? 
c. What opportunities do you have to educate patients about vaccines? 
d. Counseling or information provided to pregnant women? 
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8. Is there anything about immunizations and OB/GYNs that I haven’t asked or we 
haven’t yet talked about that you think is important? 
a. Would you be willing to review the findings from this report? 
 
Demographic Questions: 
• Describe practice: 
o Age range of patients you serve? 
o Insurance status of patients in general? 
o Size of practice – in terms of staff and number of patients? 
o In what areas of OB/GYN practice do you engage? (preconception, 
pregnancy, menopause, infertility) 
o What is your membership status in ACOG? 
o What services do you offer that might be considered more ‘primary care’ 
or that might fall outside the scope of traditional OB/GYN practice? 
o About what percentage of women in your practice would you estimate 
considers you to be their primary care provider?   
? Describe this population (age, insurance status, etc.) 
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APPENDIX D: ACIP RECOMMENDATIONS & ACOG PUBLICATIONS TABLE 
 
Vaccine Summary of ACIP Recommendations Year of ACIP 
Publication 
ACOG Committee 
Opinion Published? 
Hepatitis A • All persons wishing for protection from 
hepatitis A virus (HAV) infection 
• All previously unvaccinated children, 
adolescents, and adults age 2 years and older 
who: live in a state, county, or community with 
a routine vaccination program already in place; 
travel anywhere except U.S., W. Europe, N. 
Zealand, Australia, Canada, or Japan; have 
chronic liver disease, clotting factor disorder; 
are men who have sex with men; or are injecting 
or non-injecting drug users 
• All persons who work with HAV in 
experimental lab settings (not routine medical 
laboratories); or are food handlers when health 
authorities or private employers determine 
vaccination appropriate 
• All unvaccinated adults age 40 years or 
younger with recent (within 2 weeks) exposure 
to HAV 
(IAC, 2008a; IAC, 2008b) 
2006 No formal opinion 
published, but Hep A is 
included as part of 
periodic assessment for 
primary and preventive 
care for high-risk 
women 13 years and 
older in Committee 
Opinion #357, 
December, 2006.  
(ACOG, 2006b) 
Hepatitis B • All children age 0 through 18 years. 
• All adults wishing for protection from 
hepatitis B virus infection 
• High-risk persons, including household 
contacts and sex partners of HBsAg-positive 
persons; injecting drug users; sexually active 
persons not in a long-term, mutually 
monogamous relationship; men who have sex 
with men; persons with HIV; persons seeking 
evaluation or treatment for an STD; patients 
receiving hemodialysis and patients with renal 
disease that may result in dialysis; health care 
personnel and public safety workers who are 
exposed to blood; clients and staff of institutions 
for the developmentally disabled; inmates of 
long-term correctional facilities; and certain 
international travelers 
• Persons with chronic liver disease 
(IAC, 2008a; IAC, 2008b) 
2005 
(adolescents) 
and 2006 
(adults) 
No formal opinion 
published, but Hep B is 
included as part of 
periodic assessment for 
primary and preventive 
care for all women 13-
18 years and all high-
risk women 19 years 
and older in Committee 
Opinion #357, 
December, 2006. 
(ACOG, 2006b) 
Herpes Zoster 
(shingles) 
• Persons age 60 years and older 
(IAC, 2008a) 
2008 No formal opinion 
published, and no 
mention in the periodic 
assessment for primary 
and preventive care. 
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Vaccine Summary of ACIP Recommendations Year of ACIP 
Publication 
ACOG Committee 
Opinion Published? 
HPV • Give 3-dose series to girls at age 11–12 years 
(May be given as early as age 9 years) 
• All previously unvaccinated women through 
age 26 years 
(IAC, 2008a; IAC, 2008b) 
2007 Yes, in Committee 
Opinion #344, 
September, 2006. 
(ACOG, 2006a) 
Influenza • All children and teens age 6 months through 
18 years, as well as all household contacts of 
infants and children through age 59 months. 
• Persons age 19 years and older who have a 
risk factor (e.g., pregnancy, heart or lung 
disease, renal, hepatic, hematologic, or 
metabolic disorder [including diabetes], 
immunosuppression, or have a condition that 
compromises respiratory function or the 
handling of respiratory secretions or that can 
increase the risk of aspiration) or live in a 
chronic-care facility; or live or work with at-risk 
people as listed above 
• All other persons who want to reduce the 
likelihood of becoming ill with influenza or of 
spreading it to others 
• All persons age 50 years and older 
• Women who will be pregnant during the 
influenza season (December–spring) 
• All health care personnel and other persons 
who provide direct care to high-risk people. 
• Household contacts and out-of-home 
caregivers of children age 0–59 months 
• Travelers at risk for complications of influenza 
who go to areas where influenza activity exists 
or who may be among people from areas of the 
world where there is current influenza activity 
(e.g., on organized tours ) 
• Students or other persons 
(IAC, 2008a; IAC, 2008b) 
2008 Yes, for women during 
pregnancy in 
Committee Opinion 
#305, November, 2004. 
(ACOG, 2004) 
 
 Also included as part 
of periodic assessment 
for primary and 
preventive care for all 
women 50 years and 
older and for high-risk 
women between 13 and 
49 years in Committee 
Opinion #357, 
December, 2006. 
(ACOG, 2006b) 
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Vaccine Summary of ACIP Recommendations Year of ACIP 
Publication 
ACOG Committee 
Opinion Published? 
Meningococcal • All adolescents age 11 through 18 years 
should be given a one-time dose of MCV4 
• All college freshmen living in dorms who 
have not been vaccinated 
• All children age 2 years and older who have 
any of the following risk factors: anatomic or 
functional asplenia, or terminal complement 
component deficiency; travel to or reside in 
countries in which meningococcal disease is 
hyperendemic or epidemic (e.g., the 
“meningitis belt” of Sub-Saharan Africa) 
• Microbiologists routinely exposed to isolates 
of N. meningitides 
(IAC, 2008a; IAC, 2008b) 
2005 Yes, in Committee 
Opinion #314, 
September, 2005. 
(ACOG, 2005b) 
MMR • Persons born in 1957 or later (especially 
those born outside the U.S.) should receive at 
least one dose of MMR if there is no serologic 
proof of immunity or documentation of a dose 
given on or after the first birthday 
• Persons in high-risk groups, such as health 
care personnel (paid, unpaid, or volunteer), 
students entering college and other post–high 
school educational institutions, and 
international travelers, should receive a total 
of 2 doses 
• Women of childbearing age who do not have 
acceptable evidence of rubella immunity or 
vaccination 
(IAC, 2008a) 
1998 Yes, for rubella 
vaccine in Committee 
Opinion #281, 
December, 2002. 
(ACOG, 2002) 
 
 Also MMR is 
included as part of 
periodic assessment 
for primary and 
preventive care for 
high-risk women 
between 13 and 64 
years in Committee 
Opinion #357, 
December, 2006. 
(ACOG, 2006b) 
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Vaccine Summary of ACIP Recommendations Year of ACIP 
Publication 
ACOG Committee 
Opinion Published? 
Tdap • All adolescents age 11–12 years should 
receive one booster dose of Tdap vaccine if 5 
years have elapsed since last dose DTaP 
• All adolescents who have not received 
previous Tdap should receive one-time dose. 
Special efforts should be made to give Tdap 
to persons age 11years and older who are in 
contact with infants younger than age 12 
months or are health care workers with direct 
patient contact 
• All adults younger than age 65 years who 
have not already received Tdap 
• Adults in contact with infants younger than 
age 12 months (e.g., parents, grandparents 
younger than age 65 years, childcare 
providers, and health care personnel) who 
have not received a dose of Tdap should be 
prioritized for vaccination 
• Health care personnel who work in hospitals 
or ambulatory care settings and have direct 
patient contact and who have not received it 
(IAC, 2008a; IAC, 2008b) 
2006 
(adolescents 
and adults) 
No formal opinion 
published, but Tdap 
is included as part of 
periodic assessment 
for primary and 
preventive care for all 
women 13-64 years 
in Committee 
Opinion #357, 
December, 2006.   
 
The Td booster is 
included in the 
assessment for 
women 65 years and 
older.  
(ACOG, 2006b) 
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Vaccine Summary of ACIP Recommendations Year of ACIP 
Publication 
ACOG Committee 
Opinion Published? 
Pneumococcal • Persons age 65 years and older 
• Persons who have chronic illness or other 
risk factors, including chronic cardiac or 
pulmonary disease, chronic liver disease, 
alcoholism, diabetes, CSF leaks, cigarette 
smoking, as well as people living in special 
environments or social settings (including 
Alaska Natives and certain American Indian 
populations age 50 through 64 years if 
recommended by local public health 
authorities) 
• Those at highest risk of fatal pneumococcal 
infection, including persons who have 
anatomic asplenia, functional asplenia, or 
sickle cell disease; have an 
immunocompromising condition, including 
HIV infection, leukemia, lymphoma, 
Hodgkin’s disease, multiple myeloma, 
generalized malignancy, chronic renal failure, 
or nephrotic syndrome; are receiving 
immunosuppressive chemotherapy (including 
corticosteroids); have received an organ or 
bone marrow transplant; or are candidates for 
or recipients of cochlear implants 
(IAC, 2008a) 
1997 No formal opinion 
published, but 
pneumococcal is 
included as part of 
periodic assessment 
for primary and 
preventive care for all 
women 65 years and 
older and for high-
risk women between 
13 and 64 years in 
Committee Opinion 
#357, December, 
2006. 
(ACOG, 2006b) 
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APPENDIX E: IRB APPROVED CONSENT DOCUMENT 
 
CONSENT DOCUMENT  
 
Title of Research Study:  How Obstetricians and Gynecologists Perceive their Role in 
Vaccination: A Phenomenological Approach.   
 
Principal Investigator: Amanda Dayton 
 
Institution: East Carolina University 
 
Address:  5539 Crabtree Park Ct. Raleigh, NC 27612 
 
Telephone #: 919-523-4440  
 
INTRODUCTION 
You have been asked to participate in a research study being conducted by Amanda 
Dayton.  The purpose of this qualitative research study is to explore and understand how 
obstetrician-gynecologists perceive, define and derive meaning from their role in 
immunizations.  You are specifically invited to participate in a one-on-one interview that, 
with your permission, will be audiotaped.  The discussion will be focused on exploring 
your personal experience associated with immunizations.    
PURPOSE AND PROCEDURES 
The purpose of this research is to understand how OB/GYNs perceive, define and derive 
meaning from their role in providing patient education about immunizations and in 
administering vaccines.  In addition, the study will seek to identify the influences that 
have impacted your adolescent and adult immunization practices.   
 
In participating in this research, you will be requested to offer your opinions, feedback 
and suggestions about immunizations during an interview with the researcher.  With your 
permission, your interview will be audiotaped.  However, your identity will remain 
anonymous through the use of a pseudonym.  The data provided during your interview 
will be combined with data from interviews with other OB/GYNs and submitted in the 
form of a manuscript for professional presentations or publication.  Your name will never 
be associated with the data since pseudonyms are the only identifiers used during and 
after data collection.  Any other identifying information will be changed to protect your 
anonymity.   
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POTENTIAL RISKS AND DISCOMFORTS  
Any risks associated with this study are anticipated to be minimal.  It is a remote 
possibility that you may experience some emotional discomfort due to being asked 
questions about your immunization practices and beliefs.  This discomfort should not be 
significant. Participation in the study is entirely voluntary and can be terminated at any 
time.   
POTENTIAL BENEFITS 
The knowledge gained from this study will be of value to the field of health education 
and promotion and to vaccine-related educational programming.   
 
A potential benefit of this research to you is that your participation may cause you to 
reflect on your immunization-related beliefs and possibly on your immunization 
practices.  You will also have opportunities to share your concerns or problems related to 
the provision of immunizations.    
 
SUBJECT PRIVACY AND CONFIDENTIALITY OF RECORDS 
 
Your privacy and confidentiality will be maintained in the final report of findings from this 
study because no name or identifying information will be connected with any of the 
perceptions that you express or experiences that you share.  In addition, only the principal 
investigator will have access to the audiotape, and the principal investigator will be the only 
individual to listen to and transcribe the audiotape.   
 
All information collected during this study will be stored in a locked safe for three years.  
The principal investigator will be the only person with access to the locked safe.  After 
three years, the audiotapes, signed informed consent forms, and transcripts will be 
destroyed.   
COSTS OF PARTICIPATION & COMPENSATION  
You will not incur any associated costs as a result of participating in this research study.    
 
You will not receive any monetary compensation for your participation in this study. 
 
The interview is expected to take approximately one hour to complete.   
VOLUNTARY PARTICIPATION 
Participating in this study is voluntary.  If you decide not to be in this study after it has 
already started, you may stop at any time without penalty. 
148  
 
PERSONS TO CONTACT WITH QUESTIONS 
The investigators will be available to answer any questions concerning this research, now 
or in the future.  You may contact the investigator Amanda Dayton at phone numbers 
919-707-5565 (days) or 919-523-4440 (nights and weekends).  If you have questions 
about your rights as a research subject, you may call the Chair of the University and 
Medical Center Institutional Review Board at phone number 252-744-2914 (days).  If 
you would like to report objections to this research study, you may call the ECU Director 
of Research Compliance at phone number 252-328-9473 (for research studies conducted 
through ECU) or the PCMH Risk Management Office at 252-847-5246 (for research 
studies conducted through PCMH). 
 
CONFLICTS OF INTEREST 
 
Neither the research site, nor Amanda Dayton will receive any financial benefit based on 
the results of this study.  
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CONSENT TO PARTICIPATE 
 
Title of research study:  How Obstetricians and Gynecologists Perceive their Role in 
Vaccination: A Phenomenological Approach.   
 
I have read all of the above information, asked questions and have received satisfactory 
answers in areas I did not understand.  (A copy of this signed and dated consent form will 
be given to the person signing this form as the participant or as the participant’s 
authorized representative.) 
 
             
Participant's Name (PRINT)                                 Signature                            Date               Time 
 
 
 
 
PERSON ADMINISTERING CONSENT:  I have conducted the consent process 
and orally reviewed the contents of the consent document. I believe the participant 
understands the research. 
 
             
Person Obtaining Consent (PRINT)                      Signature                                    Date   
 
 
             
Principal Investigator's (PRINT)                           Signature                                    Date   
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